<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2d1 20170631//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article" dtd-version="1.2d1" specific-use="production" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">BIORXIV</journal-id>
<journal-title-group>
<journal-title>bioRxiv</journal-title>
<abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title>
</journal-title-group>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1101/087619</article-id>
<article-version>1.1</article-version>
<article-categories>
<subj-group subj-group-type="author-type">
<subject>Regular Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>New Results</subject>
</subj-group>
<subj-group subj-group-type="hwp-journal-coll">
<subject>Bioinformatics</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Systematic integration of biomedical knowledge prioritizes drugs for repurposing</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Himmelstein</surname>
<given-names>Daniel S</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lizee</surname>
<given-names>Antoine</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hessler</surname>
<given-names>Christine</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brueggeman</surname>
<given-names>Leo</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Sabrina L</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hadley</surname>
<given-names>Dexter</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Green</surname>
<given-names>Ari</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Khankhanian</surname>
<given-names>Pouya</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baranzini</surname>
<given-names>Sergio E</given-names>
</name>
</contrib>
</contrib-group>
<author-notes>
<fn><p><email>daniel.himmelstein@gmail.com</email>, <email>Sergio.Baranzini@ucsf.edu</email></p></fn>
</author-notes>
<pub-date pub-type="epub">
<year>2016</year>
</pub-date>
<elocation-id>087619</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>11</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>11</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2016, Posted by Cold Spring Harbor Laboratory</copyright-statement>
<copyright-year>2016</copyright-year>
<license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p></license>
</permissions>
<self-uri xlink:href="087619.pdf" content-type="pdf" xlink:role="full-text"/>
<abstract>
<title>Abstract</title>
<p>The ability to computationally predict whether a compound treats a disease would improve the economy and success rate of drug approval. This study describes the Rephetio Project to systematically model drug efficacy based on 755 existing treatments. First, we constructed Hetionet (<ext-link ext-link-type="uri" xlink:href="https://neo4j.het.io">https://neo4j.het.io</ext-link>), an integrative network encoding knowledge from millions of biomedical studies. Hetionet v1.0 consists of 47,031 nodes of 11 types and 2,250,197 relationships of 24 types. Data was integrated from 29 public resources to connect compounds, diseases, genes, anatomies, pathways, biological processes, molecular functions, cellular components, pharmacologic classes, side effects, and symptoms. Next, we identified network patterns that distinguish treatments from non-treatments. Then we predicted the probability of treatment for 209,168 compound&#x2013;;disease pairs (<ext-link ext-link-type="uri" xlink:href="http://het.io/repurpose">http://het.io/repurpose</ext-link>). Our predictions validated in two external datasets, suggesting they will help prioritize drug repurposing candidates. This study was entirely open and received realtime feedback from 36 community members.</p>
</abstract>
<counts>
<page-count count="51"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>The cost of developing a new therapeutic drug has been estimated at 1.4 billion dollars [<xref ref-type="bibr" rid="c1">1</xref>], the process typically takes 15 years from lead compound to market [<xref ref-type="bibr" rid="c2">2</xref>], and the likelihood of success is stunningly low [<xref ref-type="bibr" rid="c3">3</xref>]. Strikingly, the costs have been doubling every 9 years since 1970, a sort of inverse Moore's law, which is far from an optimal strategy from both a business and public health perspective [<xref ref-type="bibr" rid="c4">4</xref>]. Drug repurposing &#x2014; identifying novel uses for existing therapeutics &#x2014; can drastically reduce the duration, failure rates, and costs of approval [<xref ref-type="bibr" rid="c5">5</xref>]. These benefits stem from the rich preexisting information on approved drugs, including extensive toxicology profiling performed during development, preclinical models, clinical trials, and postmarketing surveillance.</p>
<p>Drug repurposing is poised to become more efficient as mining of electronic health records (EHRs) to retrospectively assess the effect of drugs gains feasibility [<xref ref-type="bibr" rid="c6">6</xref>, <xref ref-type="bibr" rid="c7">7</xref>, <xref ref-type="bibr" rid="c8">8</xref>, <xref ref-type="bibr" rid="c9">9</xref>].</p>
<p>However, systematic approaches to repurpose drugs based on mining EHRs alone will likely lack power due to multiple testing. Similar to the approach followed to increase the power of genome-wide association studies (GWAS) [<xref ref-type="bibr" rid="c10">10</xref>, <xref ref-type="bibr" rid="c11">11</xref>], integration of biological knowledge to prioritize drug repurposing will help overcome limited EHR sample size and data quality.</p>
<p>In addition to repurposing, several other paradigm shifts in drug development have been proposed to improve efficiency. Since small molecules tend to bind to many targets, polypharmacology aims to find synergy in the multiple effects of a drug [<xref ref-type="bibr" rid="c12">12</xref>]. Network pharmacology assumes diseases consist of a multitude of molecular alterations resulting in a robust disease state. Network pharmacology seeks to uncover multiple points of intervention into a specific pathophysiological state that together rehabilitate an otherwise resilient disease process [<xref ref-type="bibr" rid="c13">13</xref>, <xref ref-type="bibr" rid="c14">14</xref>]. Although target-centric drug discovery has dominated the field for decades, phenotypic screens have more recently resulted in a comparatively higher number of first-in-class small molecules [<xref ref-type="bibr" rid="c15">15</xref>]. Recent technological advances have enabled a new paradigm in which mid- to high-throughput assessment of intermediate phenotypes, such as the molecular response to drugs, is replacing the classic target discovery approach [<xref ref-type="bibr" rid="c16">16</xref>, <xref ref-type="bibr" rid="c17">17</xref>, <xref ref-type="bibr" rid="c18">18</xref>]. Furthermore, integration of multiple channels of evidence, particularly diverse types of data, can overcome the limitations and weak performance inherent to data of a single domain [<xref ref-type="bibr" rid="c19">19</xref>]. Modern computational approaches offer a convenient platform to tie these developments together as the reduced cost and increased velocity of <italic>in silico</italic> experimentation massively lowers the barriers to entry and price of failure [<xref ref-type="bibr" rid="c20">20</xref>, <xref ref-type="bibr" rid="c21">21</xref>].</p>
<p>Hetnets (short for heterogeneous networks) are networks with multiple types of nodes and relationships. They offer an intuitive, versatile and powerful structure for data integration. In this study, we developed a hetnet (Hetionet v1.0) by integrating knowledge and experimental findings from decades of biomedical research spanning millions of publications. We adapted an algorithm originally developed for social network analysis and applied it to Hetionet v1.0 to identify patterns of efficacy and predict new uses for drugs. The algorithm performs edge prediction through a machine learning framework that accommodates the breadth and depth of information contained in Hetionet v1.0 [<xref ref-type="bibr" rid="c22">22</xref>, <xref ref-type="bibr" rid="c23">23</xref>]. Our approach represents an <italic>in silico</italic> implementation of network pharmacology that natively incorporates polypharmacology and high-throughput phenotypic screening.</p>
<p>One fundamental characteristic of our method is that it learns and evaluates itself on existing medical indications (i.e. a &#x201C;gold standard &#x201D;). Next, we introduce previous approaches that also performed comprehensive evaluation on existing treatments. A 2011 study, named PREDICT, compiled 1,933 treatments between 593 drugs and 313 diseases [<xref ref-type="bibr" rid="c24">24</xref>]. Starting from the premise that similar drugs treat similar diseases, PREDICT trained a classifier that incorporates 5 types of drug-drug and 2 types of disease-disease similarity. A 2014 study compiled 890 treatments between 152 drugs and 145 diseases with transcriptional signatures [<xref ref-type="bibr" rid="c25">25</xref>]. The authors found that compounds triggering an opposing transcriptional response to the disease were more likely to be treatments, although this effect was weak and limited to cancers. A 2016 study compiled 402 treatments between 238 drugs and 78 diseases and used a single proximity score &#x2014; the average shortest path distance between a drug's targets and disease's associated proteins on the interactome &#x2014; as a classifier [<xref ref-type="bibr" rid="c26">26</xref>].</p>
<p>We build on these successes by creating a framework for incorporating the effects of any biological relationship into the prediction of whether a drug treats a disease. By doing this, we were able to capture a multitude of effects that have been suggested as influential for drug repurposing including drug-drug similarity [<xref ref-type="bibr" rid="c24">24</xref>, <xref ref-type="bibr" rid="c27">27</xref>], disease-disease similarity [<xref ref-type="bibr" rid="c24">24</xref>, <xref ref-type="bibr" rid="c28">28</xref>], transcriptional signatures [<xref ref-type="bibr" rid="c25">25</xref>, <xref ref-type="bibr" rid="c29">29</xref>, <xref ref-type="bibr" rid="c17">17</xref>, <xref ref-type="bibr" rid="c30">30</xref>, <xref ref-type="bibr" rid="c18">18</xref>], protein interactions [<xref ref-type="bibr" rid="c26">26</xref>], genetic association [<xref ref-type="bibr" rid="c31">31</xref>, <xref ref-type="bibr" rid="c32">32</xref>], drug side effects [<xref ref-type="bibr" rid="c33">33</xref>, <xref ref-type="bibr" rid="c34">34</xref>], disease symptoms [<xref ref-type="bibr" rid="c35">35</xref>], and molecular pathways [<xref ref-type="bibr" rid="c36">36</xref>]. Our ability to create such an integrative model of drug efficacy relies on the hetnet data structure to unite diverse information. On Hetionet v1.0, our algorithm learns which types of compound&#x2013;disease paths discriminate treatments from non-treatments in order to predict the probability that a compound treats a disease.</p>
<p>We refer to this study as Project Rephetio (pronounced as rep-<italic>het</italic>-<italic>ee</italic>-oh). Both Rephetio and Hetionet are portmanteaus combining the words repurpose, heterogeneous, and network with the URL het.io.</p>
</sec>
<sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Hetionet v1.0</title>
<p>We obtained and integrated data from 29 publicly available resources to create Hetionet v1.0 (<xref ref-type="fig" rid="fig1">Figure 1</xref>). The hetnet contains 47,031 nodes of 11 types (<xref ref-type="table" rid="tbl1">Table 1</xref>) and 2,250,197 relationships of 24 types (<xref ref-type="table" rid="tbl2">Table 2</xref>). The nodes consist of 1,552 small molecule compounds and 137 complex diseases, as well as genes, anatomies, pathways, biological processes, molecular functions, cellular components, perturbations, pharmacologic classes, drug side effects, and disease symptoms. The edges represent relationships between these nodes and encompass the collective knowledge produced by millions of studies over the last half century.</p>
<fig id="fig1" position="float" fig-type="figure">
<label>Figure 1.</label>
<caption><p><bold>Hetionet v1.0</bold></p>
<p>A) The metagraph, a schema of the network types. B) The hetnet visualized. Nodes are drawn as dots and laid out orbitally, thus forming circles. Edges are colored by type. C) Metapath counts by path length. The number of different types of paths of a given length that connect two node types is shown. For example, the top-left tile in the Length 1 panel denotes that Anatomy nodes are not connected to themselves (i.e. no edges connect nodes of this type between themselves). However, the bottom-left tile of the Length 4 panel denotes that 88 types of length-four paths connect Symptom to Anatomy nodes.</p></caption>
<graphic xlink:href="087619_fig1.tif"/>
</fig>
<table-wrap id="tbl1" orientation="portrait" position="float">
<label>Table 1.</label>
<caption><p><bold>Metanodes</bold></p>
<p>Hetionet v1.0 includes 11 node types (metanodes). For each metanode, this table shows the abbreviation, number of nodes, number of nodes without any edges, and the number of metaedges connecting the metanode.</p></caption>
<graphic xlink:href="087619_tbl1.tif"/>
</table-wrap>
<table-wrap id="tbl2" orientation="portrait" position="float">
<label>Table 2.</label>
<caption><p><bold>Metaedges</bold></p>
<p>Hetionet v1.0 contains 24 edge types (metaedges). For each metaedge, the table reports the abbreviation, the number of edges, the number of source nodes connected by the edges, and the number of target nodes connected by the edges. Note that all metaedges besides <italic>Generegulates Gene</italic>are undirected.</p></caption>
<graphic xlink:href="087619_tbl2.tif"/>
<graphic xlink:href="087619_tbl2a.tif"/>
</table-wrap>
<p>For example, <italic>Compound</italic>&#x2013;<italic>binds</italic>&#x2013;<italic>Gene</italic> edges represent when a compound binds to a protein encoded by a gene. This information has been extracted from the literature by human curators and compiled into databases such as DrugBank, ChEMBL, DrugCentral, and BindingDB. We combined these databases to create 11,571 binding edges between 1,389 compounds and 1,689 genes. These edges were compiled from 10,646 distinct publications, which Hetionet binding edges reference as an attribute. Binding edges represent a comprehensive catalog constructed from low throughput experimentation. However, we also integrated findings from high throughput technologies &#x2014; many of which have only recently become available. For example, we generated consensus transcriptional signatures for compounds in LINCS L1000 and diseases in STARGEO.</p>
<p>While Hetionet v1.0 is ideally suited for drug repurposing, the network has broader biological applicability. For example, we have prototyped queries for a) identifying drugs that target a specific pathway, b) identifying biological processes involved in a specific disease, c) identifying the drug targets responsible for causing a specific side effect, and d) identifying anatomies with transcriptional relevance for a specific disease [<xref ref-type="bibr" rid="c37">37</xref>]. Each of these queries was simple to write and took less than a second to run on our publicly available Hetionet Browser. While it is possible that existing services provide much of the aforementioned functionality, they offer less versatility. Hetionet differentiates itself in its ability to flexibly query across multiple domains of information. As a proof of concept, we enhanced the biological process query (b), which identified processes that were enriched for disease-associated genes, using multiple sclerosis (MS) as an example disease. The enhanced query identified genes that interact with MS GWAS-genes. However, interacting genes were discarded unless they were upregulated in an MS-related anatomy (i.e. anatomical structure, e.g. organ or tissue). Then relevant biological processes were identified. Thus, the single query spanned 4 node and 5 relationship types. Furthermore, the portion of the query to identify paths meeting the above specification required only four lines of Cypher code.</p>
<p>The integrative potential of Hetionet v1.0 is reflected by its connectivity. Among the 11 metanodes, there are 66 possible source&#x2013;target pairs. However, only 11 of them have at least one direct connection. In contrast, for paths of length 2, 50 pairs have connectivity (paths types that start on the source node type and end on the target node type, see <xref ref-type="fig" rid="fig1">Figure 1C</xref>). At length 3, all 66 pairs are connected. At length 4, the source&#x2013;target pair with the fewest types of connectivity (Side Effect to Symptom) has 13 metapaths, while the pair with the most connectivity types (Gene to Gene) has 3,542 pairs. This high level of connectivity across a diversity of biomedical entities forms the foundation for automated translation of knowledge into biomedical insight.</p>
<p>Hetionet v1.0 is accessible via a Neo4j Browser at <ext-link ext-link-type="uri" xlink:href="https://neo4j.het.io">https://neo4j.het.io</ext-link>. This public Neo4j instance provides users an installation-free method to query and visualize the network. The Browser contains a tutorial guide as well as guides with the details of each Project Rephetio prediction. Hetionet v1.0 is also available for downloadin JSON, Neo4j, and TSV formats. The JSON and Neo4j database formats include node and edge properties &#x2014; such as URLs, source and license information, and confidence scores &#x2014; and are thus recommended.</p>
</sec>
<sec id="s2b">
<title>Systematic mechanisms of efficacy</title>
<p>One aim of Project Rephetio was to systematically evaluate how drugs exert their therapeutic potential. To address this question, we compiled a gold standard of 755 disease-modifying indications, which form the <italic>Compound&#x2013;treats&#x2013;Disease</italic> edges in Hetionet v1.0. Next, we identified types of paths (metapaths) that occurred more frequently between treatments than non-treatments (any compound&#x2013;disease pair that is not a treatment). The advantage of this approach is that metapaths naturally correspond to mechanisms of pharmacological efficacy. For example, the <italic>Compound&#x2013;binds&#x2013;Gene&#x2013;associates&#x2013;Disease</italic>(<italic>CbGaD</italic>) metapath identifies when a drug binds to a protein corresponding to a gene involved in the disease.</p>
<p>We evaluated all 1,206 metapaths that traverse from compound to disease and have length of 2&#x2013;4 (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). To control for the different degrees of nodes, we used the degree-weighted path count (<italic>DWPC</italic>) &#x2014; which downweights paths going through highly-connected nodes [<xref ref-type="bibr" rid="c22">22</xref>] &#x2014; to assess path prevalence. In addition, we compared the performance of each metapath to a baseline computed from permuted networks. Hetnet permutation preserves node degree while eliminating edge specificity, allowing us to isolate the portion of unpermuted metapath performance resulting from actual network paths. We refer to the permutation-adjusted performance measure as &#x0394; AUROC.</p>
<fig id="fig2" position="float" fig-type="figure">
<label>Figure 2.</label>
<caption><p><bold>Performance by type and model coefficients</bold></p>
<p>A) The performance of the DWPCs for 1,206 metapaths, organized by their composing metaedges. The larger dots represent metapaths that were significantly affected by permutation (false discovery rate &#x003C; 5&#x0025;). Metaedges are ordered by their best performing metapath. Since a metapath's performance is limited by its least informative metaedge, the best performing metapath for a metaedge provides a lower bound on the pharmacologic utility of a given domain of information. B) Barplot of the model coefficients. Features were standardized prior to model fitting to make the coefficients comparable [<xref ref-type="bibr" rid="c38">38</xref>].</p></caption>
<graphic xlink:href="087619_fig2.tif"/>
</fig>
<p>Overall, 709 of the 1,206 metapaths exhibited a statistically significant &#x0394; AUROC at a false discovery rate cutoff of 5&#x0025;. These 709 metapaths included all 24 metaedges, suggesting that each type of relationship we integrated provided at least some therapeutic utility. However, not all metaedges were equally present in significant metapaths: 259 significant metapaths included a <italic>Compound&#x2013;binds&#x2013;Gene</italic> metaedge, whereas only 4 included a <italic>Gene&#x2013;participates&#x2013;Cellular Component</italic> metaedge. <xref ref-type="table" rid="tbl3">Table 3</xref> lists the predictiveness of several metapaths of interest. Refer to the Discussionfor our interpretation of these findings.</p>
<table-wrap id="tbl3" orientation="portrait" position="float">
<label>Table 3.</label>
<caption><p><bold>The predictiveness of select metapaths</bold></p>
<p>A small selection of the 1,206 metapathsis provided. Len. refers to number of metaedges composing the metapath. &#x0394; AUROC and &#x2212;log10(<italic>p</italic>) assess the performance of a metapath's DWPC in discriminating treatments from non-treatments (in the all-features stage as described in Methods). <italic>p</italic> assesses whether permutation affected AUROC. For reference, <italic>p</italic> = 0.05 corresponds to &#x2212;log10(<italic>p</italic>) = 1.30. Note that several metapaths shown here provided little evidence that &#x0394; AUROC &#x2260; 0 underscoring their poor ability to predict whether a compound treated a disease. Coef. reports a metapath's logistic regression coefficient as seen in <xref ref-type="fig" rid="fig2">Figure 2B</xref>. Metapaths removed in feature selection have missing coefficients whereas metapaths given zero-weight by the elastic net have coef. = 0.0.</p></caption>
<graphic xlink:href="087619_tbl3.tif"/>
<graphic xlink:href="087619_tbl3a.tif"/>
</table-wrap>
</sec>
<sec id="s2c">
<title>Predictions of drug efficacy</title>
<p>We implemented a machine learning approach to translate the network connectivity between a compound and a disease into a probability of treatment. The approach relies on the 755 known treatments as positives and 29,044 non-treatments as negatives to train a logistic regression model. The features consisted of a prior probability of treatment, node degrees for 14 metaedges, and DWPCs for 123 metapaths that were well suited for modeling. A cross-validated elastic net was used to minimize overfitting, yielding a model with 31 features (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). The DWPC features with negative coefficients appear to be included as node-degree-capturing covariates, i.e. they reflect the general connectivity of the compound and disease rather than specific paths between them. However, the 11 DWPC features with non-negligible positive coefficients represent the most salient types of connectivity for systematically modeling drug efficacy. See the metapaths with positive coefficients in <xref ref-type="table" rid="tbl3">Table 3</xref> for unabbreviated names. As an example, the <italic>CcSEcCtD</italic> feature assesses whether the compound causes the same side effects as compounds that treat the disease. Alternatively, the <italic>CbGeAlD</italic> feature assesses whether the compound binds to genes that are expressed in the anatomies affected by the disease.</p>
<p>We applied this model to predict the probability of treatment between each of 1,538 connected compounds and each of 136 connected diseases, resulting in predictions for 209,168 compound&#x2013;disease pairs [<xref ref-type="bibr" rid="c39">39</xref>], available at <ext-link ext-link-type="uri" xlink:href="http://het.io/repurpose/">http://het.io/repurpose/</ext-link>. The 755 known disease-modifying indications were highly ranked (AUROC = 97.4&#x0025;, <xref ref-type="fig" rid="fig3">Figure 3</xref>). The predictions also successfully prioritized two external validation sets: novel indications from DrugCentral (AUROC = 85.5&#x0025;) and novel indications in clinical trial (AUROC = 70.0&#x0025;). Together, these findings indicate that Project Rephetio has the ability to recognize efficacious compound&#x2013;disease pairs.</p>
<fig id="fig3" position="float" fig-type="figure">
<label>Figure 3.</label>
<caption><p><bold>Predictions performance on four indication sets</bold></p>
<p>We assess how well our predictions prioritize four sets of indications. A) The y-axis labels denote the number of indications (&#x002B;) and non-indications (&#x2212;) composing each set. Violin plots with quartile lines show the distribution of indications when compound&#x2013;disease pairs are ordered by their prediction. In all four cases, the actual indications were ranked highly by our predictions. B) ROC Curves with AUROCs in the legend. C) Precision&#x2013;Recall Curves with AUPRCs in the legend.</p></caption>
<graphic xlink:href="087619_fig3.tif"/>
</fig>
<p>Predictions were scaled to the overall prevalence of treatments (0.36&#x0025;). Hence a compound&#x2013;disease pair that received a prediction of 1&#x0025; represents a 2-fold enrichment over the null probability. Of the 3,980 predictions with a probability exceeding 1&#x0025;, 586 corresponded to known disease-modifying indications, leaving 3,394 repurposing candidates. For a given compound or disease, we provide the percentile rank of each prediction. Therefore, users can assess whether a given prediction is a top prediction for the compound or disease. In addition, our table-based prediction browser links to a custom guide for each prediction, which displays in the Neo4j Hetionet Browser. Each guide includes a query to display the top paths supporting the prediction and lists clinical trials investigating the indication.</p>
</sec>
<sec id="s2d">
<title>Nicotine dependence case study</title>
<p>There are currently two FDA-approved medications for smoking cessation (varenicline and bupropion) that are not nicotine replacement therapies. PharmacotherapyDB v1.0 lists varenicline as a disease-modifying indication and nicotine itself as a symptomatic indication for nicotine dependence, but is missing bupropion. Bupropion was first approved for depression in 1985. Owing to the serendipitous observation that it decreased smoking in depressed patients taking this drug, Bupropion was approved for smoking cessation in 1997 [<xref ref-type="bibr" rid="c40">40</xref>]. Therefore we looked whether Project Rephetio could have predicted this repurposing. Bupropion was the 9th best prediction for nicotine dependence(99.5th percentile) with a probability 2.50-fold greater than the null. <xref ref-type="fig" rid="fig4">Figure 4</xref> shows the top paths supporting the repurposing of bupropion.</p>
<fig id="fig4" position="float" fig-type="figure">
<label>Figure 4.</label>
<caption><p><bold>Evidence supporting the repurposing of bupropion for smoking cessation</bold></p>
<p>This figure shows the 10 most supportive paths (out of 365 total) for treating nicotine dependence with bupropion, as available in this prediction's Neo4j Browser guide. Our method detected that bupropion targets the <italic>CHRNA3</italic> gene, which is also targeted by the known-treatment varenicline [<xref ref-type="bibr" rid="c41">41</xref>]. Furthermore, <italic>CHRNA3</italic> is associated with nicotine dependence [<xref ref-type="bibr" rid="c42">42</xref>] and participates in several pathways that contain other nicotinic-acetylcholine-receptor (nAChRs) genes associated with nicotine dependence. Finally, bupropion causes terminal insomnia [<xref ref-type="bibr" rid="c43">43</xref>] as does varenicline [<xref ref-type="bibr" rid="c44">44</xref>], which could indicate an underlying common mechanism of action.</p></caption>
<graphic xlink:href="087619_fig4.tif"/>
</fig>
<p>Atop the nicotine dependence predictions were nicotine (10.97-fold over null), cytisine (10.58-fold), and galantamine (9.50-fold). Cytisine is widely used in Eastern Europe for smoking cessation due to its availability at a fraction of the cost of other pharmaceutical options [<xref ref-type="bibr" rid="c45">45</xref>]. In the last half decade, large scale clinical trials have confirmed cytisine's efficacy [<xref ref-type="bibr" rid="c46">46</xref>, <xref ref-type="bibr" rid="c47">47</xref>]. Galantamine, an approved Alzheimer's treatment, is currently in Phase 2 trialfor smoking cessation and is showing promising results [<xref ref-type="bibr" rid="c48">48</xref>]. In summary, nicotine dependence illustrates Project Rephetio's ability to predict efficacious treatments and prioritize historic and contemporary repurposing opportunities.</p>
</sec>
<sec id="s2e">
<title>Epilepsy case study</title>
<p>Several factors make epilepsy an interesting disease for evaluating repurposing predictions [<xref ref-type="bibr" rid="c49">49</xref>]. Antiepileptic drugs work by increasing the seizure threshold &#x2014; the amount of electric stimulation that is required to induce seizure. The effect of a drug on the seizure threshold can be cheaply and reliably tested in rodent models. As a result, the viability of most approved drugs in treating epilepsy is known.</p>
<p>We focused our evaluation on the top 100 scoring compounds &#x2014; referred to as the epilepsy predictions in this section &#x2014; after discarding a single combination drug. We classified each compound as anti-ictogenic (seizure suppressing), unknown (no established effect on the seizure threshold), or ictogenic (seizure generating) according to medical literature [<xref ref-type="bibr" rid="c49">49</xref>]. Of the epilepsy predictions, 77 were anti-ictogenic, 8 were unknown, and 15 were ictogenic (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Notably, the predictions contained 23 of the 25 disease-modifying antiepileptics in PharamcotherapyDB v1.0.</p>
<fig id="fig5" position="float" fig-type="figure">
<label>Figure 5.</label>
<caption><p><bold>Top 100 epilepsy predictions colored by their effect on seizures</bold></p>
<p>The predicted probability of treatment versus prediction rank is plotted for the top 100 epilepsy predictions. Note that all compounds shown received probabilities far exceeding the null probability of treatment. Furthermore, the highest predictions are almost exclusively anti-ictogenic. Further down the prediction list the prevalence of drugs with an ictogenic (contraindications) or unknown (novel repurposing candidates) effect on epilepsy increases.</p></caption>
<graphic xlink:href="087619_fig5.tif"/>
</fig>
<p>Many of the 77 anti-ictogenic compounds were not first-line antiepileptic drugs. Instead, they were used as ancillary drugs in the treatment of status epilepticus. For example, we predicted four halogenated ethers, two of which (isoflurane and desflurane) are used clinically to treat life-threatening seizures that persist despite treatment [<xref ref-type="bibr" rid="c50">50</xref>]. As inhaled anesthetics, these compounds are not appropriate as daily epilepsy medications, but are feasible for refractory status epilepticus where patients are intubated.</p>
<p>Given this high precision (77&#x0025;), the 8 compounds of unknown effect are promising repurposing candidates. For example, acamprosate &#x2014; whose top prediction was epilepsy &#x2014; is a taurine analog that promotes alcohol abstinence. Support for this repurposing arose from acamprosate's positive modulation of the GABA&#x1D2C; receptor and inhibition of the glutamate receptor. If effective against epilepsy, acamprosate could serve a dual benefit for recovering alcoholics who experience seizures from alcohol withdrawal.</p>
<p>Also notable are the 15 ictogenic compounds in our top 100 predictions. As an example, we predicted five tricyclic antidepressants primarily based on their binding to the GABA&#x1D2C; receptor. However, these compounds are GABA&#x1D2C; antagonists, rather than agonists, likely resulting in their ictogenic properties.</p>
<p>As isoflurane, desflurane, and acamprosate demonstrate, Project Rephetio is capable of predicting repurposing candidates that fulfil a therapeutic niche. In addition, a portion of Rephetio's predictions are likely contraindications. However, in the case of epilepsy, where the effect of most approved drugs is known, our approach was still able to overwhelmingly prioritize ictogenic compounds.</p>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>We created Hetionet v1.0 by integrating 29 resources into a single data structure &#x2014; the hetnet. Consisting of 11 types of nodes and 24 types of relationships, Hetionet v1.0 brings more types of information together than previous leading-studies in biological data integration [<xref ref-type="bibr" rid="c51">51</xref>]. Moreover, we strove to create a reusable, extensible, and property-rich network. While all of the resources we include are publicly available, their integration was a time-intensive undertaking. Hetionet allows researchers to begin answering integrative questions without having to first spend months processing data.</p>
<p>Our public Neo4j instance allows users to immediately interact with Hetionet. Through the Cypher language, users can perform highly specialized graph queries with only a few lines of code. Queries can be executed in the web browser or programmatically from a language with a Neo4j driver. For users that are unfamiliar with Cypher, we include several example queries in a Browser guide. In contrast to traditional REST APIs, our public Neo4j instance provides users with maximal flexibility to construct custom queries by exposing the underlying database.</p>
<p>As data has grown more plentiful and diverse, so has the applicability of hetnets. Unfortunately, network science has been naturally fragmented by discipline resulting in relatively slow progress in integrating heterogeneous data. A 2014 analysis identified 78 studies using multilayer networks &#x2014; a superset of hetnets with the potential for a time dimension. However, the studies relied on 26 different terms, 9 of which had multiple definitions [<xref ref-type="bibr" rid="c52">52</xref>, <xref ref-type="bibr" rid="c53">53</xref>]. Nonetheless, core infrastructure and algorithms for hetnets are emerging. One goal of our project has been to unite hetnet research across disciplines. We approached this goal by making Project Rephetio entirely available online and inviting community feedback throughout the process [<xref ref-type="bibr" rid="c54">54</xref>].</p>
<p>Integrating every resource into a single interconnected data structure allowed us to assess systematic mechanisms of drug efficacy. Using the max performing metapath to assess the pharmacological utility of a metaedge (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), we can divide our relationships into tiers of informativeness. The top tier consists of the types of information traditionally considered by pharmacology: <italic>Compound&#x2013;treats&#x2013;Disease</italic>, <italic>Pharmacologic Class&#x2013;includes&#x2013;Compound</italic>,<italic>Compound&#x2013;resembles&#x2013;Compound</italic>, <italic>Disease&#x2013;resembles&#x2013;Disease</italic>, and<italic>Compound&#x2013;binds&#x2013;Gene</italic>. The upper-middle tier consists of types of information that have been the focus of substantial medical study, but have only recently started to play a bigger role in drug development, namely the metaedges <italic>Disease&#x2013;associates&#x2013;Gene</italic>,<italic>Compound&#x2013;causes&#x2013;Side Effect</italic>,<italic>Disease&#x2013;presents&#x2013;Symptom</italic>,<italic>Disease&#x2013;localizes&#x2013;Anatomy</italic>, and<italic>Gene&#x2013;interacts&#x2013;Gene</italic>.</p>
<p>The lower-middle tier contains the transcriptomics metaedges such as <italic>Compound&#x2013;downregulates&#x2013;Gene</italic>,<italic>Anatomy&#x2013;expresses&#x2013;Gene</italic>,<italic>Gene regulates Gene</italic> , and <italic>Disease&#x2013;downregulates&#x2013;Gene</italic>. Much excitement surrounds these resources due to their high throughput and genome-wide scope, which offers a route to drug discovery that is less biased by existing knowledge. However, our findings suggest that these resources are only moderately informative of drug efficacy. Other lower-middle tier metaedges were the product of time-intensive biological experimentation, such as <italic>Gene&#x2013;participates&#x2013;Pathway</italic>,<italic>Gene&#x2013;participates&#x2013;Molecular Function</italic>, and <italic>Gene&#x2013;participates&#x2013;Biological Process</italic>. Unlike the top tier resources, this knowledge has historically been pursued for basic science rather than primarily medical applications. The weak yet appreciable performance of the <italic>Gene&#x2013;covaries&#x2013;Gene</italic> suggests the synergy between the fields of evolutionary genomics and disease biology. The lower tier included the <italic>Gene&#x2013;participates&#x2013;Cellular Component</italic> metaedge, which may reflect that the relevance of cellular location to pharmacology is highly case dependent and not amenable to systematic profiling.</p>
<p>The performance of specific metapaths (<xref ref-type="table" rid="tbl3">Table 3</xref>) provides further insight. For example, significant emphasis has been put on the use of transcriptional data for drug repurposing [<xref ref-type="bibr" rid="c30">30</xref>]. One common approach has been to identify compounds with opposing transcriptional signatures to a disease [<xref ref-type="bibr" rid="c55">55</xref>, <xref ref-type="bibr" rid="c18">18</xref>]. However, several systematic studies report underwhelming performance of this approach [<xref ref-type="bibr" rid="c25">25</xref>, <xref ref-type="bibr" rid="c24">24</xref>, <xref ref-type="bibr" rid="c26">26</xref>] &#x2014; a finding supported by the low performance of the <italic>CuGdD</italic> and <italic>CdGuD</italic> metapaths in Project Rephetio. Nonetheless, other transcription-based methods showed some promise. Compounds with similar transcriptional signatures were prone to treating the same disease (<italic>CuGuCtD</italic> and <italic>CdGdCtD</italic> metapaths), while compounds with opposing transcriptional signatures were slightly averse to treating the same disease (<italic>CuGdCtD</italic> and <italic>CdGuCtD</italic> metapaths). In contrast, diseases with similar transcriptional profiles were not prone to treatment by the same compound (<italic>CtDdGuD</italic> and <italic>CtDuGdD</italic>).</p>
<p>By comparably assessing the informativeness of different metaedges and metapaths, Project Rephetio aims to guide future research towards promising data types and analyses. Encouragingly, most data types were at least weakly informative and hence suitable for further study. Ideally, different data types would provide orthogonal information. However, our model for whether a compound treats a disease focused on 11 metapaths &#x2014; a small portion of the hundreds of metapaths available. While parsimony aids interpretation, our model did not draw on the weakly-predictive high-throughput data types &#x2014; which are intriguing for their novelty, scalability, and cost-effectiveness &#x2014; as much as we had hypothesized.</p>
<p>Instead our model selected types of information traditionally considered in pharmacology. However unlike a pharmacologist whose area of expertise may be limited to a few drug classes, our model was able to predict probabilities of treatment for all 209,168 compound&#x2013;disease pairs. Furthermore, our model systematically learned the importance of each type of network connectivity. For any compound&#x2013;disease pair, we now can immediately provide the top network paths supporting its therapeutic efficacy. A traditional pharmacologist may be able to produce a similar explanation, but likely not until spending substantial time researching the compound's pharmacology, the disease's pathophysiology, and the molecular relationships in between. Accordingly, we hope certain predictions will spur further research, such as trials to investigate the off-label use of acamprosate for epilepsy.</p>
<p>As demonstrated by the 15 ictogenic compounds in our top 100 epilepsy predictions, Project Rephetio&#x2019;s predictions can include contraindications in addition to indications. Since many of Hetionet v1.0's relationship types are general (e.g. the <italic>Compound&#x2013;binds&#x2013;Gene</italic>relationship type conflates antagonist with agonist effects), we expect some high scoring predictions to exacerbate rather than treat the disease. However, the predictions made by Hetionet v1.0 represent such substantial relative enrichment over the null that uncovering the correct directionality is a logical next step and worth undertaking. Going forward, advances in automated mining of the scientific literature could enable extraction of precise relationship types at omics scale [<xref ref-type="bibr" rid="c56">56</xref>].</p>
<p>Future research should focus on gleaning orthogonal information from data types that are so expansive that computational methods are the only option. Our <italic>CuGuCtD</italic> feature &#x2014; measuring whether a compound upregulates the same genes as compounds which treat the disease &#x2014; is a good example. This metapath was informative by itself (&#x0394; AUROC = 4.4&#x0025;) but was not selected by the model, despite its orthogonal origin (gene expression) to selected metapaths. Using a more extensive catalog of treatments as the gold standard would be one possible approach to increase the power of feature selection.</p>
<p>Integrating more types of information into Hetionet should also be a future priority. The &#x201C;network effect &#x201D; phenomenon suggests that the addition of each new piece of information will enhance the value of Hetionet's existing information. We envision a future where all biological knowledge is encoded into a single hetnet. Hetionet v1.0 was an early attempt, and we hope the strong performance of Project Rephetio in repurposing drugs foreshadows the many applications that will thrive from encoding biology in hetnets.</p>
</sec>
<sec id="s4">
<title>Methods</title>
<p>Hetionet was built entirely from publicly available resources with the goal of integrating a broad diversity of information types of medical relevance, ranging in scale from molecular to organismal. Practical considerations such as data availability, licensing, reusability, documentation, throughput, and standardization informed our choice of resources. We abided by a simple litmus test for determining how to encode information in a hetnet: nodes represent nouns, relationships represent verbs [<xref ref-type="bibr" rid="c57">57</xref>, <xref ref-type="bibr" rid="c58">58</xref>].</p>
<p>Our method for relationship prediction creates a strong incentive to avoid redundancy, which increases the computational burden without improving performance. In a previous study to predict disease&#x2013;gene associations using a hetnet of pathophysiology [<xref ref-type="bibr" rid="c22">22</xref>], we found that different types of gene sets contributed highly redundant information. Therefore, in Hetionet v1.0 we reduced the number of gene set node types from 14 to 3 by omitting several gene set collections and aggregating all pathway nodes.</p>
<sec id="s4a">
<title>Nodes</title>
<p>Nodes encode entities. We extracted nodes from standard terminologies, which provide curated vocabularies to enable data integration and prevent concept duplication. The ease of mapping external vocabularies, adoption, and comprehensiveness were primary selection criteria. Hetionet v1.0 includes nodes from 5 ontologies &#x2014; which provide hierarchy of entities for a specific domain &#x2014; selected for their conformity to current best practices [<xref ref-type="bibr" rid="c59">59</xref>].</p>
<p>We selected 137 terms from the Disease Ontology[<xref ref-type="bibr" rid="c60">60</xref>, <xref ref-type="bibr" rid="c61">61</xref>] (which we refer to as DO Slim [<xref ref-type="bibr" rid="c62">62</xref>, <xref ref-type="bibr" rid="c63">63</xref>]) as our disease set. Our goal was to identify complex diseases that are distinct and specific enough to be clinically relevant yet general enough to be well annotated. To this end, we included diseases that have been studied by GWAS and cancer types from TopNodes_DOcancerslim[<xref ref-type="bibr" rid="c64">64</xref>]. We ensured that no DO Slim disease was a subtype of another DO Slim disease. Symptoms were extracted from MeSHby taking the 438 descendants of <italic>Signs and Symptoms</italic> [<xref ref-type="bibr" rid="c65">65</xref>, <xref ref-type="bibr" rid="c66">66</xref>].</p>
<p>Approved small molecule compounds with documented chemical structures were extracted from DrugBankversion 4.2 [<xref ref-type="bibr" rid="c67">67</xref>, <xref ref-type="bibr" rid="c68">68</xref>, <xref ref-type="bibr" rid="c69">69</xref>]. Unapproved compounds were excluded because our focus was repurposing. In addition, unapproved compounds tend to be less studied than approved compounds making them less attractive for our approach where robust network connectivity is critical. Finally, restricting to small molecules with known documented structures enabled us to map between compound vocabularies (see Mappings).</p>
<p>Side effects were extracted from SIDERversion 4.1 [<xref ref-type="bibr" rid="c70">70</xref>, <xref ref-type="bibr" rid="c71">71</xref>, <xref ref-type="bibr" rid="c72">72</xref>]. SIDER codes side effects using UMLSidentifiers [<xref ref-type="bibr" rid="c73">73</xref>], which we also adopted. Pharmacologic Classes were extracted from the DrugCentral data repository[<xref ref-type="bibr" rid="c74">74</xref>].</p>
<p>Protein-coding human genes were extracted from Entrez Gene[<xref ref-type="bibr" rid="c75">75</xref>, <xref ref-type="bibr" rid="c76">76</xref>, <xref ref-type="bibr" rid="c77">77</xref>]. Anatomical structures, which we refer to as anatomies, were extracted from Uberon[<xref ref-type="bibr" rid="c78">78</xref>]. We selected a subset of 402 Uberon terms by excluding terms known not to exist in humans and terms that were overly broad or arcane [<xref ref-type="bibr" rid="c79">79</xref>, <xref ref-type="bibr" rid="c80">80</xref>].</p>
<p>Pathways were extracted by combining human pathways from WikiPathways[<xref ref-type="bibr" rid="c81">81</xref>, <xref ref-type="bibr" rid="c82">82</xref>], Reactome[<xref ref-type="bibr" rid="c83">83</xref>], and the Pathway Interaction Database[<xref ref-type="bibr" rid="c84">84</xref>]. The latter two resources were retrieved from Pathway Commons[<xref ref-type="bibr" rid="c85">85</xref>], which compiles pathways from several providers. Duplicate pathways and pathways without multiple participating genes were removed [<xref ref-type="bibr" rid="c86">86</xref>, <xref ref-type="bibr" rid="c87">87</xref>]. Biological processes, cellular components, and molecular functions were extracted from the Gene Ontology[<xref ref-type="bibr" rid="c88">88</xref>]. Only terms with 2&#x2013;1000 annotated genes were included.</p>
</sec>
<sec id="s4b">
<title>Mappings</title>
<p>Before adding relationships, all identifiers needed to be converted into the vocabularies matching that of our nodes. Oftentimes, our node vocabularies included external mappings. For example, the Disease Ontology includes mappings to MeSH, UMLS, and the ICD, several of which we submitted during the course of this study [<xref ref-type="bibr" rid="c89">89</xref>]. In a few cases, the only option was to map using gene symbols, a disfavored method given that it can lead to ambiguities.</p>
<p>When mapping external disease concepts onto DO Slim, we used transitive closure. For example, the UMLS concept for primary progressive multiple sclerosis (C0751964) was mapped to the DO Slim term for multiple sclerosis (DOID:2377).</p>
<p>Chemical vocabularies presented the greatest mapping challenge [<xref ref-type="bibr" rid="c68">68</xref>], since these are poorly standardized [<xref ref-type="bibr" rid="c90">90</xref>]. UniChem's [<xref ref-type="bibr" rid="c91">91</xref>] Connectivity Search [<xref ref-type="bibr" rid="c92">92</xref>] was used to map compounds, which maps by atomic connectivity (based on First InChIKey Hash Blocks [<xref ref-type="bibr" rid="c93">93</xref>]) and ignores small molecular differences.</p>
</sec>
<sec id="s4c">
<title>Edges</title>
<p><italic>Anatomy&#x2013;downregulates&#x2013;Gene</italic>and<italic>Anatomy&#x2013;upregulates&#x2013;Gene</italic>edges [<xref ref-type="bibr" rid="c94">94</xref>, <xref ref-type="bibr" rid="c95">95</xref>, <xref ref-type="bibr" rid="c96">96</xref>] were extracted from Bgee[<xref ref-type="bibr" rid="c97">97</xref>], which computes differentially expressed genes by anatomy in post-juvenile adult humans. <italic>Anatomy&#x2013;expresses&#x2013;Gene</italic> edges were extracted from Bgee and TISSUES[<xref ref-type="bibr" rid="c98">98</xref>, <xref ref-type="bibr" rid="c99">99</xref>, <xref ref-type="bibr" rid="c100">100</xref>].</p>
<p><italic>Compound&#x2013;binds&#x2013;Gene</italic>edges were aggregated from BindingDB[<xref ref-type="bibr" rid="c101">101</xref>, <xref ref-type="bibr" rid="c102">102</xref>], DrugBank [<xref ref-type="bibr" rid="c103">103</xref>, <xref ref-type="bibr" rid="c67">67</xref>], and DrugCentral. Only binding relationships to single proteins with affinities of at least 1 &#x00B5;M (as determined by Kd, Ki, or IC50) were selected from the October 2015 release of BindingDB [<xref ref-type="bibr" rid="c104">104</xref>, <xref ref-type="bibr" rid="c105">105</xref>]. Target, carrier, transporter, and enzyme interactions with single proteins (i.e. excluding protein groups) were extracted from DrugBank 4.2 [<xref ref-type="bibr" rid="c106">106</xref>, <xref ref-type="bibr" rid="c69">69</xref>]. In addition, all mapping DrugCentral target relationships were included [<xref ref-type="bibr" rid="c74">74</xref>]. <italic>Compound&#x2013;treats&#x2013;Disease</italic>(disease-modifying indications) and<italic>Compound&#x2013;palliates&#x2013;Disease</italic> (symptomatic indications) edges are from PharmacotherapyDB as described in Intermediate resources. <italic>Compound&#x2013;causes&#x2013;Side Effect</italic>edges were obtained from SIDER4.1 [<xref ref-type="bibr" rid="c70">70</xref>, <xref ref-type="bibr" rid="c71">71</xref>, <xref ref-type="bibr" rid="c72">72</xref>], which uses natural language processing to identify side effects in drug labels. <italic>Compound&#x2013;resembles&#x2013;Compound</italic> relationships [<xref ref-type="bibr" rid="c107">107</xref>, <xref ref-type="bibr" rid="c69">69</xref>, <xref ref-type="bibr" rid="c108">108</xref>] represent chemical similarity and correspond to a Dice coefficient &#x2265; 0.5 [<xref ref-type="bibr" rid="c109">109</xref>] between extended connectivity fingerprints [<xref ref-type="bibr" rid="c110">110</xref>, <xref ref-type="bibr" rid="c111">111</xref>].<italic>Compound&#x2013;downregulates&#x2013;Gene</italic> and <italic>Compound&#x2013;upregulates&#x2013;Gene</italic> relationships were computed from LINCS L1000 as described in Intermediate resources.</p>
<p><italic>Disease&#x2013;associates&#x2013;Gene</italic>edges were extracted from the GWAS Catalog [<xref ref-type="bibr" rid="c112">112</xref>], DISEASES [<xref ref-type="bibr" rid="c113">113</xref>, <xref ref-type="bibr" rid="c114">114</xref>], DisGeNET [<xref ref-type="bibr" rid="c115">115</xref>, <xref ref-type="bibr" rid="c116">116</xref>], and DOAF [<xref ref-type="bibr" rid="c117">117</xref>, <xref ref-type="bibr" rid="c118">118</xref>]. The GWAS Catalogcompiles disease&#x2013;SNP associations from published GWAS [<xref ref-type="bibr" rid="c119">119</xref>]. We aggregated overlapping loci associated with each disease and identified the mode reported gene for each high confidence locus [<xref ref-type="bibr" rid="c120">120</xref>, <xref ref-type="bibr" rid="c121">121</xref>]. DISEASESintegrates evidence of association from text mining, curated catalogs, and experimental data [<xref ref-type="bibr" rid="c122">122</xref>]. Associations from DISEASES with integrated scores &#x2265; 2 were included after removing the contribution of DistiLD. DisGeNET integrates evidence from over 10 sources and reports a single score for each association [<xref ref-type="bibr" rid="c123">123</xref>]. Associations with scores &#x2265; 0.06 were included. DOAF mines Entrez Gene GeneRIFs (textual annotations of gene function) for disease mentions [<xref ref-type="bibr" rid="c124">124</xref>]. Associations with 3 or more supporting GeneRIFs were included. <italic>Disease&#x2013;downregulates&#x2013;Gene</italic> and <italic>Disease&#x2013;upregulates&#x2013;Gene</italic>relationships [<xref ref-type="bibr" rid="c125">125</xref>, <xref ref-type="bibr" rid="c126">126</xref>] were computed using STARGEO as described in Intermediate resources.</p>
<p><italic>Disease&#x2013;localizes&#x2013;Anatomy</italic>,<italic>Disease&#x2013;presents&#x2013;Symptom</italic>, and<italic>Disease&#x2013;resembles&#x2013;Disease</italic> edges were calculated from MEDLINE co-occurrence [<xref ref-type="bibr" rid="c65">65</xref>, <xref ref-type="bibr" rid="c127">127</xref>]. MEDLINE is a subset of 21 million PubMed articles for which designated human curators have assigned topics. When retrieving articles for a given topic (MeSH term), we activated two non-default search options as specified below: majr for selecting only articles where the topic is major and noexp for suppressing explosion (returning articles linked to MeSH subterms). We identified 4,161,769 articles with two or more disease topics; 696,252 articles with both a disease topic (majr) and an anatomy topic (noexp) [<xref ref-type="bibr" rid="c128">128</xref>]; and 363,928 articles with both a disease topic (majr) and a symptom topic (noexp). We used a Fisher's exact test [<xref ref-type="bibr" rid="c129">129</xref>] to identify pairs of terms that occurred together more than would be expected by chance in their respective corpus. We included co-occuring terms with <italic>p</italic> &#x003C; 0.005 in Hetionet v1.0.</p>
<p><italic>Gene&#x2013;covaries&#x2013;Gene</italic>edges represent evolutionary rate covariation &#x2265; 0.75 [<xref ref-type="bibr" rid="c130">130</xref>, <xref ref-type="bibr" rid="c131">131</xref>, <xref ref-type="bibr" rid="c132">132</xref>]. <italic>Gene&#x2013;interacts&#x2013;Gene</italic> edges [<xref ref-type="bibr" rid="c133">133</xref>, <xref ref-type="bibr" rid="c134">134</xref>] represent when two genes produce physically-interacting proteins. We compiled these interactions from the Human Interactome Database [<xref ref-type="bibr" rid="c135">135</xref>, <xref ref-type="bibr" rid="c136">136</xref>, <xref ref-type="bibr" rid="c137">137</xref>, <xref ref-type="bibr" rid="c138">138</xref>], the Incomplete Interactome [<xref ref-type="bibr" rid="c139">139</xref>], and our previous study [<xref ref-type="bibr" rid="c22">22</xref>]. <italic>Gene&#x2013;participates&#x2013;Biological Process</italic>, <italic>Gene&#x2013;participates&#x2013;Cellular Component</italic>, and<italic>Gene&#x2013;participates&#x2013;Molecular Function</italic>edges are from Gene Ontology annotations [<xref ref-type="bibr" rid="c140">140</xref>]. As described in Intermediate resources,annotations were propagated [<xref ref-type="bibr" rid="c141">141</xref>, <xref ref-type="bibr" rid="c142">142</xref>].</p>
</sec>
<sec id="s4d">
<title>Intermediate resources</title>
<p>In the process of creating Hetionet, we produced several datasets with broad applicability that extended beyond Project Rephetio. These resources are referred to as intermediate resources and described below.</p>
<sec id="s4da1">
<title>Transcriptional signatures of disease using STARGEO</title>
<p>STARGEO is a nascent platform for annotating and meta-analyzing differential gene expression experiments. The STAR acronym stands for Search-Tag-Analyze Resources, while GEO refers to the Gene Expression Omnibus [<xref ref-type="bibr" rid="c143">143</xref>, <xref ref-type="bibr" rid="c144">144</xref>]. STARGEO is a layer on top of GEO that crowdsources sample annotation and automates meta-analysis.</p>
<p>Using STARGEO, we computed differentially expressed genes between healthy and diseased samples for 49 diseases [<xref ref-type="bibr" rid="c125">125</xref>, <xref ref-type="bibr" rid="c126">126</xref>]. First, we and others created case/control tags for 66 diseases. After combing through GEO series and tagging samples, 49 diseases had sufficient data for case-control meta-analysis: multiple series with at least 3 cases and 3 controls. For each disease, we performed a random effects meta-analysis on each gene to combine log2 fold-change across series. These analyses incorporated 27,019 unique samples from 460 series on 107 platforms.</p>
<p>Differentially expressed genes (false discovery rate &#x2264; 0.05) were identified for each disease. The median number of upregulated genes per disease was 351 and the median number of downregulated genes was 340. Endogenous depression was the only of the 49 diseases without any significantly dysregulated genes.</p>
</sec>
<sec id="s4da2">
<title>Transcriptional signatures of perturbation from LINCS L1000</title>
<p>LINCS L1000 profiled the transcriptional response to small molecule and genetic interference perturbations. To increase throughput, expression was only measured for 978 genes, which were selected for their ability to impute expression of the remaining genes. A single perturbation was often assayed under a variety of conditions including cell types, dosages, timepoints, and concentrations. Each condition generates a single signature of dysregulation <italic>z</italic>-scores. We further processed these signatures to fit into our approach [<xref ref-type="bibr" rid="c145">145</xref>, <xref ref-type="bibr" rid="c146">146</xref>].</p>
<p>First we computed consensus signatures &#x2014; which meta-analyze multiple signatures to condense them into one &#x2014; for DrugBank small molecules, Entrez genes, and all L1000 perturbations [<xref ref-type="bibr" rid="c147">147</xref>, <xref ref-type="bibr" rid="c148">148</xref>]. First, we discarded non-gold (non-replicating or indistinct) signatures. Then we meta-analyzed <italic>z</italic>-scores using Stouffer's method. Each signature was weighted by its average Spearman's correlation to other signatures, with a 0.05 minimum, to de-emphasize discordant signatures. Our signatures include the 978 measured genes and the 6,489 imputed genes from the &#x201C;best inferred gene subset &#x201D;. To identify significantly dysregulated genes, we selected genes using a Bonferroni cutoff of <italic>p</italic> = 0.05 and limited the number of imputed genes to 1,000.</p>
<p>The consensus signatures for genetic perturbations allowed us to assess various characteristics of the L1000 dataset. First, we looked at whether genetic interference dysregulated its target gene in the expected direction [<xref ref-type="bibr" rid="c149">149</xref>]. Looking at measured z-scores for target genes, we found that the knockdown perturbations were highly reliable, while the overexpression perturbations were only moderately reliable with 36&#x0025; of overexpression perturbations downregulating their target. However, imputed z-scores for target genes barely exceeded chance at responding in the expected direction to interference. Hence, we concluded that the imputation quality of LINCS L1000 is poor. However, when restricting to significantly dyseregulated targets, 22 out of 29 imputed genes responded in the expected direction. This provides some evidence that the directional fidelity of imputation is higher for significantly dysregulated genes. Finally, we found that the transcriptional signatures of knocking down and overexpressing the same gene were positively correlated 65&#x0025; of the time, suggesting the presence of a general stress response [<xref ref-type="bibr" rid="c150">150</xref>].</p>
<p>Based on these findings, we performed additional filtering of signifcantly dysregulated genes when building Hetionet v1.0. <italic>Compound&#x2013;down/up-regulates&#x2013;Gene</italic> relationships were restricted to the 125 most significant per compound-direction-status combination (status refers to measured versus imputed). For genetic interference perturbations, we restricted to the 50 most significant genes per gene-direction-status combination and merged the remaining edges into a single <italic>Gene regulates Gene</italic> relationship type containing both knockdown and overexpression perturbations.</p>
</sec>
<sec id="s4da3">
<title>PharmacotherapyDB: physician curated indications</title>
<p>We created PharmacotherapyDB, an open catalog of drug therapies for disease [<xref ref-type="bibr" rid="c151">151</xref>, <xref ref-type="bibr" rid="c152">152</xref>, <xref ref-type="bibr" rid="c153">153</xref>]. Version 1.0 contains 755 disease-modifying therapies and 390 symptomatic therapies between 97 diseases and 601 compounds.</p>
<p>This resource was motivated by the need for a gold standard of medical indications to train and evaluate our approach. Initially, we identified four existing indication catalogs [<xref ref-type="bibr" rid="c154">154</xref>]: MEDI-HPS which mined indications from RxNorm, SIDER 2, MedlinePlus, and Wikipedia [<xref ref-type="bibr" rid="c155">155</xref>]; LabeledIn which extracted indications from drug labels via human curation [<xref ref-type="bibr" rid="c156">156</xref>, <xref ref-type="bibr" rid="c157">157</xref>, <xref ref-type="bibr" rid="c158">158</xref>]; EHRLink which identified medication&#x2013;problem pairs that clinicians linked together in electronic health records [<xref ref-type="bibr" rid="c159">159</xref>, <xref ref-type="bibr" rid="c160">160</xref>]; and indications from PREDICT, which were compiled from UMLS relationships, drugs.com, and drug labels [<xref ref-type="bibr" rid="c24">24</xref>]. After mapping to DO Slim and DrugBank Slim, the four resources contained 1,388 distinct indications.</p>
<p>However, we noticed that many indications were palliative and hence problematic as a gold standard of pharmacotherapy for our <italic>in silico</italic> approach. Therefore, we recruited two practicing physicians to curate the 1,388 preliminary indications [<xref ref-type="bibr" rid="c161">161</xref>]. After a pilot on 50 indications, we defined three classifications: <italic>disease modifying</italic> meaning a drug that therapeutically changes the underlying or downstream biology of the disease; <italic>symptomatic</italic>meaning a drug that treats a significant symptom of the disease; and <italic>non-indication</italic> meaning a drug that neither therapeutically changes the underlying or downstream biology nor treats a significant symptom of the disease. Both curators independently classified all 1,388 indications.</p>
<p>The two curators disagreed on 444 calls (Cohen's &#x03BA; = 49.9&#x0025;). We then recruited a third practicing physician, who reviewed all 1,388 calls and created a detailed explanation of his methodology [<xref ref-type="bibr" rid="c161">161</xref>]. We proceeded with the third curator's calls as the consensus curation. The first two curators did have reservations with classifying steroids as disease modifying for autoimmune diseases. We ultimately considered that these indications met our definition of disease modifying, which is based on a pathophysiological rather than clinical standard. Accordingly, therapies we consider disease modifying may not be used to alter long-term disease course in the modern clinic due to a poor risk&#x2013;benefit ratio.</p>
</sec>
<sec id="s4da4">
<title>User-friendly Gene Ontology annotations</title>
<p>We created a browser (<ext-link ext-link-type="uri" xlink:href="http://git.dhimmel.com/gene-ontology/">http://git.dhimmel.com/gene-ontology/</ext-link>) to provide straightforward access to Gene Ontology annotations [<xref ref-type="bibr" rid="c142">142</xref>, <xref ref-type="bibr" rid="c141">141</xref>]. Our service provides annotations between Gene Ontology terms and Entrez Genes. The user chooses propagated/direct annotation and all/experimental evidence. Annotations are currently available for 37 species and downloadable as user-friendly TSV files.</p>
</sec>
</sec>
<sec id="s4e">
<title>Data copyright and licensing</title>
<p>We committed to openly releasing our data and analyses from the origin of the project [<xref ref-type="bibr" rid="c162">162</xref>]. Our goals were to contribute to the advancement of science [<xref ref-type="bibr" rid="c163">163</xref>, <xref ref-type="bibr" rid="c164">164</xref>], maximize our impact [<xref ref-type="bibr" rid="c165">165</xref>], and enable reproducibility [<xref ref-type="bibr" rid="c166">166</xref>, <xref ref-type="bibr" rid="c167">167</xref>, <xref ref-type="bibr" rid="c168">168</xref>]. These objectives required publicly distributing and openly licensing Hetionet and Project Rephetio data and analyses [<xref ref-type="bibr" rid="c169">169</xref>, <xref ref-type="bibr" rid="c170">170</xref>].</p>
<p>Since we integrated only public resources, which were overwhelmingly funded by academic grants, we had assumed that our project and open sharing of our network would not be an issue. However, upon releasing a preliminary version of our hetnet [<xref ref-type="bibr" rid="c171">171</xref>], a community reviewer informed us of legal barriers to integrating public data. In essence, both copyright (rights of exclusivity automatically granted to original works) and terms of use (rules that users must agree to in order to use a resource) place legally-binding restrictions on data reuse.</p>
<p>Of the 29 resources we integrated, only 12 had licenses that met the Open Definition with respect to knowledge. 9 did not have a license, which equates to all rights reserved and by default forbids reuse [<xref ref-type="bibr" rid="c172">172</xref>]. Several resources had incompatible licenses caused primarily by non-commercial and share-alike stipulations. One resource included terms which explicitly forbid redistribution. In addition, it was often unclear who owned the data [<xref ref-type="bibr" rid="c173">173</xref>]. Therefore, we sought input from legal experts and chronicled our progress [<xref ref-type="bibr" rid="c174">174</xref>, <xref ref-type="bibr" rid="c175">175</xref>, <xref ref-type="bibr" rid="c176">176</xref>, <xref ref-type="bibr" rid="c177">177</xref>].</p>
<p>Ultimately, we did not find an ideal solution. We had to choose between absolute compliance and Hetionet: strictly adhering to copyright and licensing arrangements would have decimated the network. Hence we choose a path forward which balanced legal, normative, ethical, and scientific considerations. If a resource was in the public domain, for example works of the US Government, we licensed any derivatives as CC0 1.0. For resources licensed to allow use, redistribution, and modification, we transmitted their licenses as properties on the specific nodes and relationships in our hetnet. For all other resources &#x2014; for example, resources without licenses or with licenses that forbid redistribution &#x2014; we sent permission requests to their creators. The median time till first response to our permission requests was 16 days, with only 2 resources affirmatively granting us permission. We did not receive any responses asking us to remove a resource. However, we did voluntarily remove MSigDB [<xref ref-type="bibr" rid="c178">178</xref>], since its license was highly problematic [<xref ref-type="bibr" rid="c175">175</xref>].</p>
</sec>
<sec id="s4f">
<title>Permuted Hetnets</title>
<p>From Hetionet, we derived five permuted hetnets [<xref ref-type="bibr" rid="c179">179</xref>]. The permutations preserve node degree but eliminate edge specificity by employing an algorithm called XSwap to randomly swap edges [<xref ref-type="bibr" rid="c180">180</xref>]. Permuted networks are useful for computing the baseline performance of meaningless edges while preserving node degree [<xref ref-type="bibr" rid="c181">181</xref>].</p>
</sec>
<sec id="s4g">
<title>Neo4j</title>
<p>Graph database adoption in bioinformatics has thus far been limited [<xref ref-type="bibr" rid="c182">182</xref>]. We used the Neo4j graph database for storing and operating on Hetionet and noticed major benefits from tapping into this large open source ecosystem [<xref ref-type="bibr" rid="c183">183</xref>]. Persistent storage with immediate access and the Cypher query language &#x2014; a sort of SQL for hetnets &#x2014; were two of the biggest benefits. To facilitate our migration to Neo4j, we updated hetio &#x2014; our existing Python package for hetnets [<xref ref-type="bibr" rid="c184">184</xref>] &#x2014; to export networks into Neo4j and DWPC queries to Cypher. In addition, we created an interactive GraphGistfor Project Rephetio, which introduces our approach and showcases its Cypher queries. Finally, we created a public Neo4j instance[<xref ref-type="bibr" rid="c185">185</xref>], which leverages several modern technologies such Neo4j Browser guides, cloud hosting with HTTPS, and Docker deployment [<xref ref-type="bibr" rid="c186">186</xref>, <xref ref-type="bibr" rid="c187">187</xref>].</p>
</sec>
<sec id="s4h">
<title>Machine learning approach</title>
<p>We made several refinements to metapath-based hetnet edge prediction compared to previous studies [<xref ref-type="bibr" rid="c22">22</xref>, <xref ref-type="bibr" rid="c23">23</xref>]. First, we transformed DWPCs by mean scaling and then taking the inverse hyperbolic sine [<xref ref-type="bibr" rid="c188">188</xref>] to make them more amenable to modeling [<xref ref-type="bibr" rid="c189">189</xref>]. Second, we bifurcated the workflow into an all-features stage and an all-observations stage [<xref ref-type="bibr" rid="c190">190</xref>]. The all-features stage assesses feature performance and does not require computing features for all negatives. Here we selected a random subset of 3,020 (4 &#x00D7; 755) negatives. Little error was introduced by this optimization, since the predominant limitation to performance assessment was the small number of positives (755) rather than negatives. Based on the all-features performance assessment [<xref ref-type="bibr" rid="c191">191</xref>], we selected 142 DWPCs to compute on all observations (all 209,168 compound&#x2013;disease pairs). The feature selection was designed to remove uninformative features (according to permutation) and guard against edge-dropout contamination [<xref ref-type="bibr" rid="c192">192</xref>]. Third, we included 14 degree features, which assess the degree of a specific metaedge for either the source compound or target disease.</p>
<sec id="s4ha1">
<title>Prior probability of treatment</title>
<p>The 755 treatments in Hetionet v1.0 are not evenly distributed between all compounds and diseases. For example, methotrexate treats 19 diseases and hypertension is treated by 68 compounds. We estimated a prior probability of treatment &#x2014; based only on the treatment degree of the source compound and target disease &#x2014; on 744,975 permutations of the bipartite treatment network [<xref ref-type="bibr" rid="c193">193</xref>]. Methotrexate received a 79.6&#x0025; prior probability of treating hypertension, whereas a compound and disease that both had only one treatment received a prior of 0.12&#x0025;.</p>
<p>Across the 209,168 compound&#x2013;disease pairs, the prior predicted the known treatments with AUROC = 97.9&#x0025;. The strength of this association threatened to dominate our predictions. However, not modeling the prior can lead to omitted-variable bias and confounded proxy variables. To address the issue, we included the logit-transformed prior, without any regularization, as a term in the model. This restricted model fitting to the 29,799 observations with a nonzero prior &#x2014; corresponding to the 387 compounds and 77 diseases with at least one treatment. To enable predictions for all 209,168 observations, we set the prior for each compound&#x2013;disease pair to the overall prevalence of positives (0.36&#x0025;).</p>
<p>This method succeeded at accommodating the treatment degrees. The prior probabilities performed poorly on the validation sets with AUROC = 54.1&#x0025; on DrugCentral indications and AUROC = 62.5&#x0025; on clinical trials. This performance dropoff compared to training shows the danger of encoding treatment degree into predictions. The benefits of our solution are highlighted by the superior validation performance of our predictions compared to the prior (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p>
</sec>
</sec>
<sec id="s4i">
<title>Indication sets</title>
<p>We evaluated our predictions on four sets of indications as shown in <xref ref-type="fig" rid="fig3">Figure 3</xref>.</p>
<list list-type="bullet">
<list-item><p>Disease Modifying &#x2014; the 755 disease modifying treatments in PharmacotherapyDB v1.0. These indications are included in the hetnet as <italic>treats</italic> edges and used to train the logistic regression model. Due to edge dropout contamination and self-testing [<xref ref-type="bibr" rid="c192">192</xref>, <xref ref-type="bibr" rid="c194">194</xref>], overfitting could potentially inflate performance on this set. Therefore, for the three remaining indication sets, we removed any observations that were positives in this set.</p></list-item>
<list-item><p>DrugCentral &#x2014; We discovered the DrugCentral database after completing our physician curation for PharmacotherapyDB. This database contained 210 additional indications [<xref ref-type="bibr" rid="c74">74</xref>]. While we didn't curate these indications, we observed a high proportion of disease modifying therapy.</p></list-item>
<list-item><p>Clinical Trial &#x2014; We compiled indications that have been investigated by clinical trial from ClinicalTrials.gov [<xref ref-type="bibr" rid="c195">195</xref>]. This set contains 5,594 indications. Since these indications were not manually curated and clinical trials often show a lack of efficacy, we expected lower performance on this set.</p></list-item>
<list-item><p>Symptomatic &#x2014; 390 symptomatic indications from PharacotherapyDB. These edges are included in the hetnet as <italic>palliates</italic> edges.</p></list-item>
</list>
<p>Only the Clinical Trial and DrugCentral indication sets were used for external validation, since the Disease Modifying and Symptomatic indications were included in the hetnet.</p>
</sec>
<sec id="s4j">
<title>Realtime open science &#x0026; Thinklab</title>
<p>We conducted our study using Thinklab &#x2014; a platform for realtime open collaborative science &#x2014; on which this study was the first project. We began the study by publicly proposing the idea and inviting discussion [<xref ref-type="bibr" rid="c196">196</xref>]. We continued by chronicling our progress via discussions. We used Thinklab as the frontend to coordinate and report our analyses and GitHub as the backend to host our code, data, and notebooks. On top of our Thinklab team consisting of core contributors, we welcomed community contribution and review. In areas where our expertise was lacking or advice would be helpful, we sought input from domain experts and encouraged them to respond on Thinklab where their comments would be CC BY licensed and their contribution rated and rewarded.</p>
<p>In total, 36 non-team members commented across 80 discussions, which generated 488 comments and 161 notes (<xref ref-type="fig" rid="fig6">Figure 6</xref>). The Thinklab content for this project totaled 111,425 words or 698,830 characters [<xref ref-type="bibr" rid="c197">197</xref>]. Using an estimated 7,000 words per academic publication as a benchmark, Project Rephetio generated written content comparable in volume to 15.9 publications prior to its completion. We noticed several other benefits from using Thinklab including forging a community of contributors [<xref ref-type="bibr" rid="c198">198</xref>]; receiving feedback during the early stages when feedback is the most actionable [<xref ref-type="bibr" rid="c199">199</xref>]; disseminating our research without delay [<xref ref-type="bibr" rid="c200">200</xref>, <xref ref-type="bibr" rid="c201">201</xref>]; opening avenues for external input [<xref ref-type="bibr" rid="c202">202</xref>]; facilitating problem-oriented teaching [<xref ref-type="bibr" rid="c203">203</xref>, <xref ref-type="bibr" rid="c204">204</xref>]; and improving our documentation by maintaining a publication-grade digital lab notebook [<xref ref-type="bibr" rid="c205">205</xref>].</p>
<fig id="fig6" position="float" fig-type="figure">
<label>Figure 6.</label>
<caption><p><bold>The growth the Project Rephetio corpus on Thinklab over time</bold></p>
<p>This figure shows Project Rephetio contributions by user over time. Each band represented the cumulative contribution of a Thinklab user to discussions in the Rephetio project [<xref ref-type="bibr" rid="c197">197</xref>]. Users are ordered by date of first contribution. Users who contributed over 4,000 characters are named. The square root transformation of characters written per user accentuates the activity of new contributors, thereby emphasizing collaboration and diverse input.</p></caption>
<graphic xlink:href="087619_fig6.tif"/>
</fig>
</sec>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>We are immensely grateful to our Thinklab contributors who joined us in our experiment of radically open science. The following non-team members provided contributions that received 5 or more Thinklab points: Lars Juhl Jensen, Frederic Bastian, Alexander Pico, Casey Greene, Craig Knox, Benjamin Good, Chris Mungall, Katie Fortney, Venkat Malladi, MacKenzie Smith, Caty Chung, Mike Gilson, Tudor Oprea, Allison McCoy, Alexey Strokach, Ritu Khare, Marina Sirota, Greg Way, Raghavendran Partha, Jesse Spaulding, Alessandro Didonna, Alex Pankov, Janet Pi&#x00F1;ero, Oleg Ursu, Tong Shu Li. We would also like to thank Neo Technology, whose staff provided excellent technical support.</p>
<p>This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. 1144247 to DSH. SEB is supported by the Heidrich Family and Friends Foundation.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="c1"><label>1.</label><mixed-citation publication-type="journal"><article-title>Innovation in the pharmaceutical industry: New estimates of R&#x0026;D costs</article-title> <string-name><given-names>Joseph A.</given-names> <surname>DiMasi</surname></string-name>, <string-name><given-names>Henry G.</given-names> <surname>Grabowski</surname></string-name>, <string-name><given-names>Ronald W.</given-names> <surname>Hansen</surname></string-name> (<year>2016</year>) <source>Journal of Health Economics</source>. doi:<pub-id pub-id-type="doi">10.1016/j.jhealeco.2016.01.012</pub-id></mixed-citation></ref>
<ref id="c2"><label>2.</label><mixed-citation publication-type="journal"><article-title>A guide to drug discovery: Trends in development and approval times for new therapeutics in the United States</article-title> <string-name><given-names>Janice M.</given-names> <surname>Reichert</surname></string-name> (<year>2003</year>) <source>Nature Reviews Drug Discovery</source>. doi:<pub-id pub-id-type="doi">10.1038/nrd1178</pub-id></mixed-citation></ref>
<ref id="c3"><label>3.</label><mixed-citation publication-type="journal"><article-title>Clinical development success rates for investigational drugs</article-title> <string-name><surname>Michael</surname> <given-names>Hay</given-names></string-name>, <string-name><given-names>David W</given-names> <surname>Thomas</surname></string-name>, <string-name><given-names>John L</given-names> <surname>Craighead</surname></string-name>, <string-name><given-names>Celia</given-names> <surname>Economides</surname></string-name>, <string-name><given-names>Jesse</given-names> <surname>Rosenthal</surname></string-name> (<year>2014</year>) <source>Nat Biotechnol</source>. doi:<pub-id pub-id-type="doi">10.1038/nbt.2786</pub-id></mixed-citation></ref>
<ref id="c4"><label>4.</label><mixed-citation publication-type="journal"><article-title>Diagnosing the decline in pharmaceutical R&#x0026;D efficiency</article-title> <string-name><given-names>Jack W.</given-names> <surname>Scannell</surname></string-name>, <string-name><given-names>Alex</given-names> <surname>Blanckley</surname></string-name>, <string-name><given-names>Helen</given-names> <surname>Boldon</surname></string-name>, <string-name><given-names>Brian</given-names> <surname>Warrington</surname></string-name> (<year>2012</year>) <source>Nature Reviews Drug Discovery</source>. doi:<pub-id pub-id-type="doi">10.1038/nrd3681</pub-id></mixed-citation></ref>
<ref id="c5"><label>5.</label><mixed-citation publication-type="journal"><article-title>Drug repositioning: identifying and developing new uses for existing drugs</article-title> <string-name><given-names>Ted T.</given-names> <surname>Ashburn</surname></string-name>, <string-name><given-names>Karl B.</given-names> <surname>Thor</surname></string-name> (<year>2004</year>) <source>Nat Rev Drug Discov</source>. doi:<pub-id pub-id-type="doi">10.1038/nrd1468</pub-id></mixed-citation></ref>
<ref id="c6"><label>6.</label><mixed-citation publication-type="journal"><article-title>A method for systematic discovery of adverse drug events from clinical notes</article-title> <string-name><given-names>G.</given-names> <surname>Wang</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Jung</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Winnenburg</surname></string-name>, <string-name><given-names>N. H.</given-names> <surname>Shah</surname></string-name> (<year>2015</year>) <source>Journal of the American Medical Informatics Association</source>. doi:<pub-id pub-id-type="doi">10.1093/jamia/ocv102</pub-id></mixed-citation></ref>
<ref id="c7"><label>7.</label><mixed-citation publication-type="journal"><article-title>Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality</article-title> <string-name><given-names>H.</given-names> <surname>Xu</surname></string-name>, <string-name><given-names>M. C.</given-names> <surname>Aldrich</surname></string-name>, <string-name><given-names>Q.</given-names> <surname>Chen</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>N. B.</given-names> <surname>Peterson</surname></string-name>, <string-name><given-names>Q.</given-names> <surname>Dai</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Levy</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Shah</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Han</surname></string-name>, <string-name><given-names>X.</given-names> <surname>Ruan</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Jiang</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Li</surname></string-name>, <string-name><given-names>J. S.</given-names> <surname>Julien</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Warner</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Friedman</surname></string-name>, <string-name><given-names>D. M.</given-names> <surname>Roden</surname></string-name>, <string-name><given-names>J. C.</given-names> <surname>Denny</surname></string-name> (<year>2014</year>) <source>Journal of the American Medical Informatics Association</source>. doi:<pub-id pub-id-type="doi">10.1136/amiajnl-2014-002649</pub-id></mixed-citation></ref>
<ref id="c8"><label>8.</label><mixed-citation publication-type="journal"><article-title>Mining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration</article-title> <string-name><given-names>Murray H.</given-names> <surname>Brilliant</surname></string-name>, <string-name><given-names>Kamyar</given-names> <surname>Vaziri</surname></string-name>, <string-name><given-names>Thomas B.</given-names> <surname>Connor</surname></string-name>, <string-name><given-names>Stephen G.</given-names> <surname>Schwartz</surname></string-name>, <string-name><given-names>Joseph J.</given-names> <surname>Carroll</surname></string-name>, <string-name><given-names>Catherine A.</given-names> <surname>McCarty</surname></string-name>, <string-name><given-names>Steven J.</given-names> <surname>Schrodi</surname></string-name>, <string-name><given-names>Scott J.</given-names> <surname>Hebbring</surname></string-name>, <string-name><given-names>Krishna S.</given-names> <surname>Kishor</surname></string-name>, <string-name><given-names>Harry W.</given-names> <surname>Flynn</surname></string-name>, <string-name><given-names>Andrew A.</given-names> <surname>Moshfeghi</surname></string-name>, <string-name><given-names>Darius M.</given-names> <surname>Moshfeghi</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Elizabeth Fini</surname></string-name>, <string-name><given-names>Brian S.</given-names> <surname>McKay</surname></string-name> (<year>2016</year>) <source>The American Journal of Medicine</source>. doi:<pub-id pub-id-type="doi">10.1016/j.amjmed.2015.10.015</pub-id></mixed-citation></ref>
<ref id="c9"><label>9.</label><mixed-citation publication-type="journal"><article-title>Data-Driven Prediction of Drug Effects and Interactions</article-title> <string-name><given-names>N. P.</given-names> <surname>Tatonetti</surname></string-name>, <string-name><given-names>P. P.</given-names> <surname>Ye</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Daneshjou</surname></string-name>, <string-name><given-names>R. B.</given-names> <surname>Altman</surname></string-name> (<year>2012</year>) <source>Science Translational Medicine</source>. doi:<pub-id pub-id-type="doi">10.1126/scitranslmed.3003377</pub-id></mixed-citation></ref>
<ref id="c10"><label>10.</label><mixed-citation publication-type="journal"><article-title>Bayesian statistical methods for genetic association studies Matthew Stephens</article-title>, <string-name><given-names>David J.</given-names> <surname>Balding</surname></string-name> (<year>2009</year>) <source>Nat Rev Genet</source>. doi:<pub-id pub-id-type="doi">10.1038/nrg2615</pub-id></mixed-citation></ref>
<ref id="c11"><label>11.</label><mixed-citation publication-type="journal"><article-title>The complex genetics of multiple sclerosis: pitfalls and prospects</article-title> <string-name><given-names>S.</given-names> <surname>Sawcer</surname></string-name> (<year>2008</year>) <source>Brain</source>. doi:<pub-id pub-id-type="doi">10.1093/brain/awn081</pub-id></mixed-citation></ref>
<ref id="c12"><label>12.</label><mixed-citation publication-type="journal"><article-title>Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia</article-title> <string-name><given-names>Bryan L.</given-names> <surname>Roth</surname></string-name>, <string-name><given-names>Douglas J.</given-names> <surname>Sheffler</surname></string-name>, <string-name><given-names>Wesley K.</given-names> <surname>Kroeze</surname></string-name> (<year>2004</year>) <source>Nat Rev Drug Discov</source>. doi:<pub-id pub-id-type="doi">10.1038/nrd1346</pub-id></mixed-citation></ref>
<ref id="c13"><label>13.</label><mixed-citation publication-type="journal"><article-title>Network pharmacology: the next paradigm in drug discovery</article-title> <string-name><given-names>Andrew L</given-names> <surname>Hopkins</surname></string-name> (<year>2008</year>) <source>Nature Chemical Biology</source>. doi:<pub-id pub-id-type="doi">10.1038/nchembio.118</pub-id></mixed-citation></ref>
<ref id="c14"><label>14.</label><mixed-citation publication-type="journal"><article-title>Network pharmacology</article-title> <string-name><given-names>Andrew L</given-names> <surname>Hopkins</surname></string-name> (<year>2007</year>) <source>Nat Biotechnol</source>. doi:<pub-id pub-id-type="doi">10.1038/nbt1007-1110</pub-id></mixed-citation></ref>
<ref id="c15"><label>15.</label><mixed-citation publication-type="journal"><article-title>How were new medicines discovered?</article-title> <string-name><given-names>David C.</given-names> <surname>Swinney</surname></string-name>, <string-name><surname>Jason</surname> <given-names>Anthony</given-names></string-name> (<year>2011</year>) <source>Nat Rev Drug Discov</source>. doi:<pub-id pub-id-type="doi">10.1038/nrd3480</pub-id></mixed-citation></ref>
<ref id="c16"><label>16.</label><mixed-citation publication-type="journal"><article-title>Drug discovery in the age of systems biology: the rise of computational approaches for data integration</article-title> <string-name><surname>Murat</surname> <given-names>Iskar</given-names></string-name>, <string-name><surname>Georg</surname> <given-names>Zeller</given-names></string-name>, <string-name><surname>Xing-Ming</surname> <given-names>Zhao</given-names></string-name>, <string-name><surname>Vera</surname> <given-names>van Noort</given-names></string-name>, <string-name><surname>Peer</surname> <given-names>Bork</given-names></string-name> (<year>2012</year>) <source>Current Opinion in Biotechnology</source>. doi:<pub-id pub-id-type="doi">10.1016/j.copbio.2011.11.010</pub-id></mixed-citation></ref>
<ref id="c17"><label>17.</label><mixed-citation publication-type="journal"><article-title>The Connectivity Map: a new tool for biomedical research Justin Lamb</article-title> (<year>2007</year>) <source>Nature Reviews Cancer</source>. doi:<pub-id pub-id-type="doi">10.1038/nrc2044</pub-id></mixed-citation></ref>
<ref id="c18"><label>18.</label><mixed-citation publication-type="journal"><article-title>Applications of Connectivity Map in drug discovery and development</article-title> <string-name><given-names>Xiaoyan A.</given-names> <surname>Qu</surname></string-name>, <string-name><given-names>Deepak K.</given-names> <surname>Rajpal</surname></string-name> (<year>2012</year>) <source>Drug Discovery Today</source>. doi:<pub-id pub-id-type="doi">10.1016/j.drudis.2012.07.017</pub-id></mixed-citation></ref>
<ref id="c19"><label>19.</label><mixed-citation publication-type="journal"><article-title>In silicomethods for drug repurposing and pharmacology</article-title> <string-name><given-names>Rachel A.</given-names> <surname>Hodos</surname></string-name>, <string-name><given-names>Brian A.</given-names> <surname>Kidd</surname></string-name>, <string-name><surname>Khader</surname> <given-names>Shameer</given-names></string-name>, <string-name><given-names>Ben P.</given-names> <surname>Readhead</surname></string-name>, <string-name><given-names>Joel T.</given-names> <surname>Dudley</surname></string-name> (<year>2016</year>) <source>WIREs Syst Biol Med</source>. doi:<pub-id pub-id-type="doi">10.1002/wsbm.1337</pub-id></mixed-citation></ref>
<ref id="c20"><label>20.</label><mixed-citation publication-type="journal"><article-title>Computational Drug Repositioning: From Data to Therapeutics</article-title> <string-name><given-names>M R</given-names> <surname>Hurle</surname></string-name>, <string-name><given-names>L</given-names> <surname>Yang</surname></string-name>, <string-name><given-names>Q</given-names> <surname>Xie</surname></string-name>, <string-name><given-names>D K</given-names> <surname>Rajpal</surname></string-name>, <string-name><given-names>P</given-names> <surname>Sanseau</surname></string-name>, <string-name><given-names>P</given-names> <surname>Agarwal</surname></string-name> (<year>2013</year>) <source>Clin Pharmacol Ther</source>. doi:<pub-id pub-id-type="doi">10.1038/clpt.2013.1</pub-id></mixed-citation></ref>
<ref id="c21"><label>21.</label><mixed-citation publication-type="journal"><article-title>In silico drug repositioning &#x2013; what we need to know</article-title> <string-name><surname>Zhichao</surname> <given-names>Liu</given-names></string-name>, <string-name><surname>Hong</surname> <given-names>Fang</given-names></string-name>, <string-name><surname>Kelly</surname> <given-names>Reagan</given-names></string-name>, <string-name><surname>Xiaowei</surname> <given-names>Xu</given-names></string-name>, <string-name><given-names>Donna L.</given-names> <surname>Mendrick</surname></string-name>, <string-name><surname>William</surname> <given-names>Slikker</given-names></string-name>, <string-name><surname>Weida</surname> <given-names>Tong</given-names></string-name> (<year>2013</year>) <source>Drug Discovery Today</source>. doi:<pub-id pub-id-type="doi">10.1016/j.drudis.2012.08.005</pub-id></mixed-citation></ref>
<ref id="c22"><label>22.</label><mixed-citation publication-type="journal"><article-title>Heterogeneous Network Edge Prediction: A Data Integration Approach to Prioritize Disease-Associated Genes</article-title> <string-name><given-names>Daniel S.</given-names> <surname>Himmelstein</surname></string-name>, <string-name><given-names>Sergio E.</given-names> <surname>Baranzini</surname></string-name> (<year>2015</year>) <source>PLOS Computational Biology</source>. doi:<pub-id pub-id-type="doi">10.1371/journal.pcbi.1004259</pub-id></mixed-citation></ref>
<ref id="c23"><label>23.</label><mixed-citation publication-type="journal"><article-title>Co-author Relationship Prediction in Heterogeneous Bibliographic Networks</article-title> <string-name><surname>Yizhou</surname> <given-names>Sun</given-names></string-name>, <string-name><surname>Rick</surname> <given-names>Barber</given-names></string-name>, <string-name><surname>Manish</surname> <given-names>Gupta</given-names></string-name>, <string-name><given-names>Charu C.</given-names> <surname>Aggarwal</surname></string-name>, <string-name><surname>Jiawei</surname> <given-names>Han</given-names></string-name> (<year>2011</year>) <source>2011 International Conference on Advances in Social Networks Analysis and Mining</source>. doi:<pub-id pub-id-type="doi">10.1109/ASONAM.2011.112</pub-id></mixed-citation></ref>
<ref id="c24"><label>24.</label><mixed-citation publication-type="journal"><article-title>PREDICT: a method for inferring novel drug indications with application to personalized medicine</article-title> <string-name><given-names>A.</given-names> <surname>Gottlieb</surname></string-name>, <string-name><given-names>G. Y.</given-names> <surname>Stein</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Ruppin</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Sharan</surname></string-name> (<year>2011</year>) <source>Molecular Systems Biology</source>. doi:<pub-id pub-id-type="doi">10.1038/msb.2011.26</pub-id></mixed-citation></ref>
<ref id="c25"><label>25.</label><mixed-citation publication-type="journal"><article-title>Systematic evaluation of connectivity map for disease indications</article-title> <string-name><surname>Jie</surname> <given-names>Cheng</given-names></string-name>, <string-name><surname>Lun</surname> <given-names>Yang</given-names></string-name>, <string-name><surname>Vinod</surname> <given-names>Kumar</given-names></string-name>, <string-name><surname>Pankaj</surname> <given-names>Agarwal</given-names></string-name> (<year>2014</year>) <source>Genome Medicine</source>. doi:<pub-id pub-id-type="doi">10.1186/s13073-014-0095-1</pub-id></mixed-citation></ref>
<ref id="c26"><label>26.</label><mixed-citation publication-type="journal"><article-title>Network-based in silico drug efficacy screening</article-title> <string-name><surname>Emre</surname> <given-names>Guney</given-names></string-name>, <string-name><surname>J&#x00F6;rg</surname> <given-names>Menche</given-names></string-name>, <string-name><surname>Marc</surname> <given-names>Vidal</given-names></string-name>, <string-name><surname>Albert-L&#x00E1;szl&#x00F3;</surname> <given-names>Bar&#x00E1;basi</given-names></string-name> (<year>2016</year>) <source>Nature Communications</source>. doi:<pub-id pub-id-type="doi">10.1038/ncomms10331</pub-id></mixed-citation></ref>
<ref id="c27"><label>27.</label><mixed-citation publication-type="journal"><article-title>A new method for computational drug repositioning using drug pairwise similarity</article-title> <string-name><surname>Jiao</surname> <given-names>Li</given-names></string-name>, <string-name><surname>Zhiyong</surname> <given-names>Lu</given-names></string-name> (<year>2012</year>) <source>2012 IEEE International Conference on Bioinformatics and Biomedicine</source>. doi:<pub-id pub-id-type="doi">10.1109/BIBM.2012.6392722</pub-id></mixed-citation></ref>
<ref id="c28"><label>28.</label><mixed-citation publication-type="journal"><article-title>Systematic Evaluation of Drug&#x2013;Disease Relationships to Identify Leads for Novel Drug Uses</article-title> <string-name><given-names>A P</given-names> <surname>Chiang</surname></string-name>, <string-name><given-names>A J</given-names> <surname>Butte</surname></string-name> (<year>2009</year>) <source>Clin Pharmacol Ther</source>. doi:<pub-id pub-id-type="doi">10.1038/clpt.2009.103</pub-id></mixed-citation></ref>
<ref id="c29"><label>29.</label><mixed-citation publication-type="journal"><article-title>The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease</article-title> <string-name><given-names>J.</given-names> <surname>Lamb</surname></string-name> (<year>2006</year>) <source>Science</source>. doi:<pub-id pub-id-type="doi">10.1126/science.1132939</pub-id></mixed-citation></ref>
<ref id="c30"><label>30.</label><mixed-citation publication-type="journal"><article-title>Transcriptional data: a new gateway to drug repositioning?</article-title> <string-name><surname>Francesco</surname> <given-names>Iorio</given-names></string-name>, <string-name><surname>Timothy</surname> <given-names>Rittman</given-names></string-name>, <string-name><surname>Hong</surname> <given-names>Ge</given-names></string-name>, <string-name><surname>Michael</surname> <given-names>Menden</given-names></string-name>, <string-name><surname>Julio</surname> <given-names>Saez-Rodriguez</given-names></string-name> (<year>2013</year>) <source>Drug Discovery Today</source>. doi:<pub-id pub-id-type="doi">10.1016/j.drudis.2012.07.014</pub-id></mixed-citation></ref>
<ref id="c31"><label>31.</label><mixed-citation publication-type="journal"><article-title>The support of human genetic evidence for approved drug indications</article-title> <string-name><surname>Matthew</surname> <given-names>R Nelson</given-names></string-name>, <string-name><surname>Hannah</surname> <given-names>Tipney</given-names></string-name>, <string-name><given-names>Jeffery L</given-names> <surname>Painter</surname></string-name>, <string-name><surname>Judong</surname> <given-names>Shen</given-names></string-name>, <string-name><surname>Paola</surname> <given-names>Nicoletti</given-names></string-name>, <string-name><surname>Yufeng</surname> <given-names>Shen</given-names></string-name>, <string-name><surname>Aris</surname> <given-names>Floratos</given-names></string-name>, <string-name><surname>Pak Chung</surname> <given-names>Sham</given-names></string-name>, <string-name><surname>Mulin</surname> <given-names>Jun Li</given-names></string-name>, <string-name><surname>Junwen</surname> <given-names>Wang</given-names></string-name>, <string-name><given-names>Lon R</given-names> <surname>Cardon</surname></string-name>, <string-name><given-names>John C</given-names> <surname>Whittaker</surname></string-name>, <string-name><surname>Philippe</surname> <given-names>Sanseau</given-names></string-name> (<year>2015</year>) <source>Nature Genetics</source>. doi:<pub-id pub-id-type="doi">10.1038/ng.3314</pub-id></mixed-citation></ref>
<ref id="c32"><label>32.</label><mixed-citation publication-type="journal"><article-title>Use of genome-wide association studies for drug repositioning</article-title> <string-name><surname>Philippe</surname> <given-names>Sanseau</given-names></string-name>, <string-name><surname>Pankaj</surname> <given-names>Agarwal</given-names></string-name>, <string-name><given-names>Michael R</given-names> <surname>Barnes</surname></string-name>, <string-name><surname>Tomi</surname> <given-names>Pastinen</given-names></string-name>, <string-name><given-names>J Brent</given-names> <surname>Richards</surname></string-name>, <string-name><given-names>Lon R</given-names> <surname>Cardon</surname></string-name>, <string-name><surname>Vincent</surname> <given-names>Mooser</given-names></string-name> (<year>2012</year>) <source>Nat Biotechnol</source>. doi:<pub-id pub-id-type="doi">10.1038/nbt.2151</pub-id></mixed-citation></ref>
<ref id="c33"><label>33.</label><mixed-citation publication-type="journal"><article-title>Drug Target Identification Using Side-Effect Similarity</article-title> <string-name><given-names>M.</given-names> <surname>Campillos</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Kuhn</surname></string-name>, <string-name><given-names>A.-C.</given-names> <surname>Gavin</surname></string-name>, <string-name><given-names>L. J.</given-names> <surname>Jensen</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Bork</surname></string-name> (<year>2008</year>) <source>Science</source>. doi:<pub-id pub-id-type="doi">10.1126/science.1158140</pub-id></mixed-citation></ref>
<ref id="c34"><label>34.</label><mixed-citation publication-type="journal"><article-title>Computational drug repositioning based on side-effects mined from social media</article-title> <string-name><surname>Timothy</surname> <given-names>Nugent</given-names></string-name>, <string-name><surname>Vassilis</surname> <given-names>Plachouras</given-names></string-name>, <string-name><given-names>Jochen L.</given-names> <surname>Leidner</surname></string-name> (<year>2016</year>) <source>PeerJ Computer Science</source>. doi:<pub-id pub-id-type="doi">10.7717/peerj-cs.46</pub-id></mixed-citation></ref>
<ref id="c35"><label>35.</label><mixed-citation publication-type="journal"><article-title>Human symptoms&#x2013;disease network</article-title> <string-name><surname>XueZhong</surname> <given-names>Zhou</given-names></string-name>, <string-name><surname>J&#x00F6;rg</surname> <given-names>Menche</given-names></string-name>, <string-name><surname>Albert-L&#x00E1;szl&#x00F3;</surname> <given-names>Barab&#x00E1;si</given-names></string-name>, <string-name><surname>Amitabh</surname> <given-names>Sharma</given-names></string-name> (<year>2014</year>) <source>Nat Comms</source>. doi:<pub-id pub-id-type="doi">10.1038/ncomms5212</pub-id></mixed-citation></ref>
<ref id="c36"><label>36.</label><mixed-citation publication-type="journal"><article-title>Pathway-based Bayesian inference of drug&#x2013;disease interactions</article-title> <string-name><surname>Naruemon</surname> <given-names>Pratanwanich</given-names></string-name>, <string-name><surname>Pietro</surname> <given-names>Li&#x00F3;</given-names></string-name> (<year>2014</year>) <source>Mol. BioSyst</source>.. doi:<pub-id pub-id-type="doi">10.1039/C4MB00014E</pub-id></mixed-citation></ref>
<ref id="c37"><label>37.</label><mixed-citation publication-type="journal"><article-title>Exploring the power of Hetionet: a Cypher query depot</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name> (<year>2016</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d220</pub-id></mixed-citation></ref>
<ref id="c38"><label>38.</label><mixed-citation publication-type="journal"><article-title>Computing standardized logistic regression coefficients</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Antoine</surname> <given-names>Lizee</given-names></string-name> (<year>2016</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d205</pub-id></mixed-citation></ref>
<ref id="c39"><label>39.</label><mixed-citation publication-type="journal"><article-title>Predictions of whether a compound treats a disease</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Chrissy</surname> <given-names>Hessler</given-names></string-name>, <string-name><surname>Pouya</surname> <given-names>Khankhanian</given-names></string-name> (<year>2016</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d203</pub-id></mixed-citation></ref>
<ref id="c40"><label>40.</label><mixed-citation publication-type="journal"><article-title>Development of Novel Pharmacotherapeutics for Tobacco Dependence: Progress and Future Directions</article-title> <string-name><given-names>D.</given-names> <surname>Harmey</surname></string-name>, <string-name><given-names>P. R.</given-names> <surname>Griffin</surname></string-name>, <string-name><given-names>P. J.</given-names> <surname>Kenny</surname></string-name> (<year>2012</year>) <source>Nicotine &#x0026; Tobacco Research</source>. doi:<pub-id pub-id-type="doi">10.1093/ntr/nts201</pub-id></mixed-citation></ref>
<ref id="c41"><label>41.</label><mixed-citation publication-type="journal"><article-title>Varenicline Is a Partial Agonist at 4beta2 and a Full Agonist at 7 Neuronal Nicotinic Receptors</article-title> <string-name><given-names>K. B.</given-names> <surname>Mihalak</surname></string-name> (<year>2006</year>) <source>Molecular Pharmacology</source>. doi:<pub-id pub-id-type="doi">10.1124/mol.106.025130</pub-id></mixed-citation></ref>
<ref id="c42"><label>42.</label><mixed-citation publication-type="journal"><article-title>A variant associated with nicotine dependence, lung cancer and peripheral arterial disease</article-title> <string-name><given-names>Thorgeir E.</given-names> <surname>Thorgeirsson</surname></string-name>, <string-name><surname>Frank</surname> <given-names>Geller</given-names></string-name>, <string-name><surname>Patrick</surname> <given-names>Sulem</given-names></string-name>, <string-name><surname>Thorunn</surname> <given-names>Rafnar</given-names></string-name>, <string-name><surname>Anna</surname> <given-names>Wiste</given-names></string-name>, <string-name><given-names>Kristinn P.</given-names> <surname>Magnusson</surname></string-name>, <string-name><surname>Andrei</surname> <given-names>Manolescu</given-names></string-name>, <string-name><surname>Gudmar</surname> <given-names>Thorleifsson</given-names></string-name>, <string-name><surname>Hreinn</surname> <given-names>Stefansson</given-names></string-name>, <string-name><surname>Andres</surname> <given-names>Ingason</given-names></string-name>, <string-name><given-names>Simon N.</given-names> <surname>Stacey</surname></string-name>, <string-name><given-names>Jon T.</given-names> <surname>Bergthorsson</surname></string-name>, <string-name><surname>Steinunn</surname> <given-names>Thorlacius</given-names></string-name>, <string-name><surname>Julius</surname> <given-names>Gudmundsson</given-names></string-name>, <string-name><surname>Thorlakur</surname> <given-names>Jonsson</given-names></string-name>, <string-name><surname>Margret</surname> <given-names>Jakobsdottir</given-names></string-name>, <string-name><surname>Jona</surname> <given-names>Saemundsdottir</given-names></string-name>, <string-name><surname>Olof</surname> <given-names>Olafsdottir</given-names></string-name>, <string-name><given-names>Larus J.</given-names> <surname>Gudmundsson</surname></string-name>, <string-name><surname>Gyda</surname> <given-names>Bjornsdottir</given-names></string-name>, <string-name><surname>Kristleifur</surname> <given-names>Kristjansson</given-names></string-name>, <string-name><surname>Halla</surname> <given-names>Skuladottir</given-names></string-name>, <string-name><given-names>Helgi J.</given-names> <surname>Isaksson</surname></string-name>, <string-name><surname>Tomas</surname> <given-names>Gudbjartsson</given-names></string-name>, <string-name><given-names>Gregory T.</given-names> <surname>Jones</surname></string-name>, <string-name><surname>Thomas</surname> <given-names>Mueller</given-names></string-name>, <string-name><surname>Anders</surname> <given-names>Gotts&#x00E4;ter</given-names></string-name>, <string-name><surname>Andrea</surname> <given-names>Flex</given-names></string-name>, <string-name><given-names>Katja K. H.</given-names> <surname>Aben</surname></string-name>, <string-name><surname>Femmie</surname> <given-names>de Vegt</given-names></string-name>, <string-name><given-names>Peter F. A.</given-names> <surname>Mulders</surname></string-name>, <string-name><surname>Dolores</surname> <given-names>Isla</given-names></string-name>, <string-name><given-names>Maria J.</given-names> <surname>Vidal</surname></string-name>, <string-name><surname>Laura</surname> <given-names>Asin</given-names></string-name>, <string-name><surname>Berta</surname> <given-names>Saez</given-names></string-name>, <string-name><surname>Laura</surname> <given-names>Murillo</given-names></string-name>, <string-name><surname>Thorsteinn</surname> <given-names>Blondal</given-names></string-name>, <string-name><surname>Halldor</surname> <given-names>Kolbeinsson</given-names></string-name>, <string-name><given-names>Jon G.</given-names> <surname>Stefansson</surname></string-name>, <string-name><surname>Ingunn</surname> <given-names>Hansdottir</given-names></string-name>, <string-name><surname>Valgerdur</surname> <given-names>Runarsdottir</given-names></string-name>, <string-name><surname>Roberto</surname> <given-names>Pola</given-names></string-name>, <string-name><surname>Bengt</surname> <given-names>Lindblad</given-names></string-name>, <string-name><given-names>Andre M.</given-names> <surname>van Rij</surname></string-name>, <string-name><surname>Benjamin</surname> <given-names>Dieplinger</given-names></string-name>, <string-name><surname>Meinhard</surname> <given-names>Haltmayer</given-names></string-name>, <string-name><given-names>Jose I.</given-names> <surname>Mayordomo</surname></string-name>, <string-name><given-names>Lambertus A.</given-names> <surname>Kiemeney</surname></string-name>, <string-name><given-names>Stefan E.</given-names> <surname>Matthiasson</surname></string-name>, <string-name><surname>Hogni</surname> <given-names>Oskarsson</given-names></string-name>, <string-name><surname>Thorarinn</surname> <given-names>Tyrfingsson</given-names></string-name>, <string-name><given-names>Daniel F.</given-names> <surname>Gudbjartsson</surname></string-name>, <string-name><given-names>Jeffrey R.</given-names> <surname>Gulcher</surname></string-name>, <string-name><surname>Steinn</surname> <given-names>Jonsson</given-names></string-name>, <string-name><surname>Unnur</surname> <given-names>Thorsteinsdottir</given-names></string-name>, <string-name><surname>Augustine</surname> <given-names>Kong</given-names></string-name>, <string-name><surname>Kari</surname> <given-names>Stefansson</given-names></string-name> (<year>2008</year>) <source>Nature</source>. doi:<pub-id pub-id-type="doi">10.1038/nature06846</pub-id></mixed-citation></ref>
<ref id="c43"><label>43.</label><mixed-citation publication-type="journal"><article-title>Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000</article-title> <string-name><surname>Andrew</surname> <given-names>Boshier</given-names></string-name>, <string-name><given-names>Lynda V.</given-names> <surname>Wilton</surname></string-name>, <string-name><given-names>Saad A. W.</given-names> <surname>Shakir</surname></string-name> (<year>2003</year>) <source>European Journal of Clinical Pharmacology</source>. doi:<pub-id pub-id-type="doi">10.1007/s00228-003-0693-0</pub-id></mixed-citation></ref>
<ref id="c44"><label>44.</label><mixed-citation publication-type="journal"><article-title>Efficacy and Safety of Varenicline for Smoking Cessation</article-title> <string-name><given-names>J.</given-names> <surname>Taylor Hays</surname></string-name>, <string-name><given-names>Jon O.</given-names> <surname>Ebbert</surname></string-name>, <string-name><surname>Amit</surname> <given-names>Sood</given-names></string-name> (<year>2008</year>) <source>The American Journal of Medicine</source>. doi:<pub-id pub-id-type="doi">d10.1016/j.amjmed.2008.01.017</pub-id></mixed-citation></ref>
<ref id="c45"><label>45.</label><mixed-citation publication-type="journal"><article-title>Nicotine receptor partial agonists for smoking cessation</article-title> <string-name><surname>Kate</surname> <given-names>Cahill</given-names></string-name>, <string-name><surname>Nicola</surname> <given-names>Lindson-Hawley</given-names></string-name>, <string-name><given-names>Kyla H</given-names> <surname>Thomas</surname></string-name>, <string-name><given-names>Thomas R</given-names> <surname>Fanshawe</surname></string-name>, <string-name><surname>Tim</surname> <given-names>Lancaster</given-names></string-name> (<year>2016</year>) <source>Cochrane Database of Systematic Reviews</source>. doi:<pub-id pub-id-type="doi">10.1002/14651858.CD006103.pub7</pub-id></mixed-citation></ref>
<ref id="c46"><label>46.</label><mixed-citation publication-type="journal"><article-title>Placebo-Controlled Trial of Cytisine for Smoking Cessation</article-title> <string-name><surname>Robert</surname> <given-names>West</given-names></string-name>, <string-name><surname>Witold</surname> <given-names>Zatonski</given-names></string-name>, <string-name><surname>Magdalena</surname> <given-names>Cedzynska</given-names></string-name>, <string-name><surname>Dorota</surname> <given-names>Lewandowska</given-names></string-name>, <string-name><surname>Joanna</surname> <given-names>Pazik</given-names></string-name>, <string-name><surname>Paul</surname> <given-names>Aveyard</given-names></string-name>, <string-name><surname>John</surname> <given-names>Stapleton</given-names></string-name> (<year>2011</year>) <source>New England Journal of Medicine</source>. doi:<pub-id pub-id-type="doi">10.1056/NEJMoa1102035</pub-id></mixed-citation></ref>
<ref id="c47"><label>47.</label><mixed-citation publication-type="journal"><article-title>Cytisine versus Nicotine for Smoking Cessation</article-title> <string-name><surname>Natalie</surname> <given-names>Walker</given-names></string-name>, <string-name><surname>Colin</surname> <given-names>Howe</given-names></string-name>, <string-name><surname>Marewa</surname> <given-names>Glover</given-names></string-name>, <string-name><surname>Hayden</surname> <given-names>McRobbie</given-names></string-name>, <string-name><surname>Joanne</surname> <given-names>Barnes</given-names></string-name>, <string-name><surname>Vili</surname> <given-names>Nosa</given-names></string-name>, <string-name><surname>Varsha</surname> <given-names>Parag</given-names></string-name>, <string-name><surname>Bruce</surname> <given-names>Bassett</given-names></string-name>, <string-name><surname>Christopher</surname> <given-names>Bullen</given-names></string-name> (<year>2014</year>) <source>New England Journal of Medicine</source>. doi:<pub-id pub-id-type="doi">10.1056/NEJMoa1407764</pub-id></mixed-citation></ref>
<ref id="c48"><label>48.</label><mixed-citation publication-type="journal"><article-title>Repeated administration of an acetylcholinesterase inhibitor attenuates nicotine taking in rats and smoking behavior in human smokers</article-title> <string-name><given-names>R L</given-names> <surname>Ashare</surname></string-name>, <string-name><given-names>B A</given-names> <surname>Kimmey</surname></string-name>, <string-name><given-names>L E</given-names> <surname>Rupprecht</surname></string-name>, <string-name><given-names>M E</given-names> <surname>Bowers</surname></string-name>, <string-name><given-names>M R</given-names> <surname>Hayes</surname></string-name>, <string-name><given-names>H D</given-names> <surname>Schmidt</surname></string-name> (<year>2016</year>) <source>Translational Psychiatry</source>. doi:<pub-id pub-id-type="doi">10.1038/tp.2015.209</pub-id></mixed-citation></ref>
<ref id="c49"><label>49.</label><mixed-citation publication-type="journal"><article-title>Prediction in epilepsy</article-title> <string-name><surname>Pouya</surname> <given-names>Khankhanian</given-names></string-name>, <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name> (<year>2016</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d224</pub-id></mixed-citation></ref>
<ref id="c50"><label>50.</label><mixed-citation publication-type="journal"><article-title>Treatment of Refractory Status Epilepticus With Inhalational Anesthetic Agents Isoflurane and Desflurane</article-title> <string-name><given-names>Seyed M.</given-names> <surname>Mirsattari</surname></string-name>, <string-name><given-names>Michael D.</given-names> <surname>Sharpe</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Bryan Young</surname></string-name> (<year>2004</year>) <source>Archives of Neurology</source>. doi:<pub-id pub-id-type="doi">10.1001/archneur.61.8.1254</pub-id></mixed-citation></ref>
<ref id="c51"><label>51.</label><mixed-citation publication-type="journal"><article-title>Methods for biological data integration: perspectives and challenges</article-title> <string-name><surname>Vladimir</surname> <given-names>Gligorijevi&#x0107;</given-names></string-name>, <string-name><surname>Nata&#x0161;a</surname> <given-names>Pr&#x017E;ulj</given-names></string-name> (<year>2015</year>) <source>J. R. Soc. Interface</source>. doi:<pub-id pub-id-type="doi">10.1098/rsif.2015.0571</pub-id></mixed-citation></ref>
<ref id="c52"><label>52.</label><mixed-citation publication-type="journal"><article-title>Multilayer networks</article-title> <string-name><given-names>M.</given-names> <surname>Kivela</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Arenas</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Barthelemy</surname></string-name>, <string-name><given-names>J. P.</given-names> <surname>Gleeson</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Moreno</surname></string-name>, <string-name><given-names>M. A.</given-names> <surname>Porter</surname></string-name> (<year>2014</year>) <source>Journal of Complex Networks</source>. doi:<pub-id pub-id-type="doi">10.1093/comnet/cnu016</pub-id></mixed-citation></ref>
<ref id="c53"><label>53.</label><mixed-citation publication-type="journal"><article-title>Renaming &#x2018;heterogeneous networks&#x2019; to a more concise and catchy term</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Casey</surname> <given-names>Greene</given-names></string-name>, <string-name><surname>Sergio</surname> <given-names>Baranzini</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d104</pub-id></mixed-citation></ref>
<ref id="c54"><label>54.</label><mixed-citation publication-type="journal"><article-title>Rephetio: Repurposing drugs on a hetnet [project]</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Antoine</surname> <given-names>Lizee</given-names></string-name>, <string-name><surname>Pouya</surname> <given-names>Khankhanian</given-names></string-name>, <string-name><surname>Leo</surname> <given-names>Brueggeman</given-names></string-name>, <string-name><surname>Sabrina</surname> <given-names>Chen</given-names></string-name>, <string-name><surname>Dexter</surname> <given-names>Hadley</given-names></string-name>, <string-name><surname>Chrissy</surname> <given-names>Hessler</given-names></string-name>, <string-name><surname>Ari</surname> <given-names>Green</given-names></string-name>, <string-name><surname>Sergio</surname> <given-names>Baranzini</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.4</pub-id></mixed-citation></ref>
<ref id="c55"><label>55.</label><mixed-citation publication-type="journal"><article-title>Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data</article-title> <string-name><given-names>M.</given-names> <surname>Sirota</surname></string-name>, <string-name><given-names>J. T.</given-names> <surname>Dudley</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Kim</surname></string-name>, <string-name><given-names>A. P.</given-names> <surname>Chiang</surname></string-name>, <string-name><given-names>A. A.</given-names> <surname>Morgan</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Sweet-Cordero</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Sage</surname></string-name>, <string-name><given-names>A. J.</given-names> <surname>Butte</surname></string-name> (<year>2011</year>) <source>Science Translational Medicine</source>. doi:<pub-id pub-id-type="doi">10.1126/scitranslmed.3001318</pub-id></mixed-citation></ref>
<ref id="c56"><label>56.</label><mixed-citation publication-type="journal"><article-title>Data programming with DDLite</article-title> <string-name><given-names>Henry R.</given-names> <surname>Ehrenberg</surname></string-name>, <string-name><surname>Jaeho</surname> <given-names>Shin</given-names></string-name>, <string-name><given-names>Alexander J.</given-names> <surname>Ratner</surname></string-name>, <string-name><given-names>Jason A.</given-names> <surname>Fries</surname></string-name>, <string-name><surname>Christopher</surname> <given-names>R&#x00E9;</given-names></string-name> (<year>2016</year>) <source>Proceedings of the Workshop on Human-In-the-Loop Data Analytics - HILDA &#x2019;16</source>. doi:<pub-id pub-id-type="doi">10.1145/2939502.2939515</pub-id></mixed-citation></ref>
<ref id="c57"><label>57.</label><mixed-citation publication-type="journal"><article-title>English, Chinese and ER diagrams</article-title> <string-name><surname>Peter</surname> <given-names>Pin-Shan Chen</given-names></string-name> (<year>1997</year>) <source>Data &#x0026; Knowledge Engineering</source>. doi:<pub-id pub-id-type="doi">10.1016/s0169-023x(97)00017-7</pub-id></mixed-citation></ref>
<ref id="c58"><label>58.</label><mixed-citation publication-type="journal"><article-title>Data nomenclature: naming and abbreviating our network types</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Lars</surname> <given-names>Juhl Jensen</given-names></string-name>, <string-name><surname>Pouya</surname> <given-names>Khankhanian</given-names></string-name> (<year>2016</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d162</pub-id></mixed-citation></ref>
<ref id="c59"><label>59.</label><mixed-citation publication-type="journal"><article-title>Ten Simple Rules for Selecting a Bio-ontology</article-title> <string-name><surname>James</surname> <given-names>Malone</given-names></string-name>, <string-name><surname>Robert</surname> <given-names>Stevens</given-names></string-name>, <string-name><surname>Simon</surname> <given-names>Jupp</given-names></string-name>, <string-name><surname>Tom</surname> <given-names>Hancocks</given-names></string-name>, <string-name><surname>Helen</surname> <given-names>Parkinson</given-names></string-name>, <string-name><surname>Cath</surname> <given-names>Brooksbank</given-names></string-name> (<year>2016</year>) <source>PLOS Computational Biology</source>. doi:<pub-id pub-id-type="doi">10.1371/journal.pcbi.1004743</pub-id></mixed-citation></ref>
<ref id="c60"><label>60.</label><mixed-citation publication-type="journal"><article-title>Disease Ontology: a backbone for disease semantic integration</article-title> <string-name><given-names>L. M.</given-names> <surname>Schriml</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Arze</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Nadendla</surname></string-name>, <string-name><given-names>Y.-W. W.</given-names> <surname>Chang</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Mazaitis</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Felix</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Feng</surname></string-name>, <string-name><given-names>W. A.</given-names> <surname>Kibbe</surname></string-name> (<year>2011</year>) <source>Nucleic Acids Research</source>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkr972</pub-id></mixed-citation></ref>
<ref id="c61"><label>61.</label><mixed-citation publication-type="journal"><article-title>Disease Ontology 2015 update: an expanded and updated database of human diseases for linking biomedical knowledge through disease data</article-title> <string-name><given-names>W. A.</given-names> <surname>Kibbe</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Arze</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Felix</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Mitraka</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Bolton</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Fu</surname></string-name>, <string-name><given-names>C. J.</given-names> <surname>Mungall</surname></string-name>, <string-name><given-names>J. X.</given-names> <surname>Binder</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Malone</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Vasant</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Parkinson</surname></string-name>, <string-name><given-names>L. M.</given-names> <surname>Schriml</surname></string-name> (<year>2014</year>) <source>Nucleic Acids Research</source>. doi:<pub-id pub-id-type="doi">10.1093/nar/gku1011</pub-id></mixed-citation></ref>
<ref id="c62"><label>62.</label><mixed-citation publication-type="journal"><article-title>Unifying disease vocabularies</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Tong Shu</surname> <given-names>Li</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d44</pub-id></mixed-citation></ref>
<ref id="c63"><label>63.</label><mixed-citation publication-type="journal"><article-title>User-friendly extensions to the Disease Ontology v1.0</article-title> <string-name><given-names>Daniel S.</given-names> <surname>Himmelstein</surname></string-name> (<year>2016</year>) <source>Zenodo</source>. doi:<pub-id pub-id-type="doi">10.5281/zenodo.45584</pub-id></mixed-citation></ref>
<ref id="c64"><label>64.</label><mixed-citation publication-type="journal"><article-title>Generating a focused view of disease ontology cancer terms for pan-cancer data integration and analysis</article-title> <string-name><given-names>T.-J.</given-names> <surname>Wu</surname></string-name>, <string-name><given-names>L. M.</given-names> <surname>Schriml</surname></string-name>, <string-name><given-names>Q.-R.</given-names> <surname>Chen</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Colbert</surname></string-name>, <string-name><given-names>D. J.</given-names> <surname>Crichton</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Finney</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Hu</surname></string-name>, <string-name><given-names>W. A.</given-names> <surname>Kibbe</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Kincaid</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Meerzaman</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Mitraka</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Pan</surname></string-name>, <string-name><given-names>K. M.</given-names> <surname>Smith</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Srivastava</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Ward</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Yan</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Mazumder</surname></string-name> (<year>2015</year>) <source>Database</source>. doi:<pub-id pub-id-type="doi">10.1093/database/bav032</pub-id></mixed-citation></ref>
<ref id="c65"><label>65.</label><mixed-citation publication-type="journal"><article-title>Mining knowledge from MEDLINE articles and their indexed MeSH terms</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Alex</surname> <given-names>Pankov</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d67</pub-id></mixed-citation></ref>
<ref id="c66"><label>66.</label><mixed-citation publication-type="journal"><article-title>User-friendly extensions to MeSH v1.0</article-title> <string-name><given-names>Daniel S.</given-names> <surname>Himmelstein</surname></string-name> (<year>2016</year>) <source>Zenodo</source>. doi:<pub-id pub-id-type="doi">10.5281/zenodo.45586</pub-id></mixed-citation></ref>
<ref id="c67"><label>67.</label><mixed-citation publication-type="journal"><article-title>DrugBank 4.0: shedding new light on drug metabolism</article-title> <string-name><given-names>V.</given-names> <surname>Law</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Knox</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Djoumbou</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Jewison</surname></string-name>, <string-name><given-names>A. C.</given-names> <surname>Guo</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Liu</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Maciejewski</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Arndt</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Wilson</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Neveu</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Tang</surname></string-name>, <string-name><given-names>G.</given-names> <surname>Gabriel</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Ly</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Adamjee</surname></string-name>, <string-name><given-names>Z. T.</given-names> <surname>Dame</surname></string-name>, <string-name><given-names>B.</given-names> <surname>Han</surname></string-name>, <string-name><given-names>Y.</given-names> <surname>Zhou</surname></string-name>, <string-name><given-names>D. S.</given-names> <surname>Wishart</surname></string-name> (<year>2013</year>) <source>Nucleic Acids Research</source>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkt1068</pub-id></mixed-citation></ref>
<ref id="c68"><label>68.</label><mixed-citation publication-type="journal"><article-title>Unifying drug vocabularies</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d40</pub-id></mixed-citation></ref>
<ref id="c69"><label>69.</label><mixed-citation publication-type="journal"><article-title>User-friendly extensions of the DrugBank database v1.0</article-title> <string-name><given-names>Daniel S.</given-names> <surname>Himmelstein</surname></string-name> (<year>2016</year>) <source>Zenodo</source>. doi:<pub-id pub-id-type="doi">10.5281/zenodo.45579</pub-id></mixed-citation></ref>
<ref id="c70"><label>70.</label><mixed-citation publication-type="journal"><article-title>The SIDER database of drugs and side effects</article-title> <string-name><surname>Michael</surname> <given-names>Kuhn</given-names></string-name>, <string-name><surname>Ivica</surname> <given-names>Letunic</given-names></string-name>, <string-name><surname>Lars</surname> <given-names>Juhl Jensen</given-names></string-name>, <string-name><surname>Peer</surname> <given-names>Bork</given-names></string-name> (<year>2015</year>) <source>Nucleic Acids Res</source>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkv1075</pub-id></mixed-citation></ref>
<ref id="c71"><label>71.</label><mixed-citation publication-type="journal"><article-title>Extracting side effects from SIDER 4</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d97</pub-id></mixed-citation></ref>
<ref id="c72"><label>72.</label><mixed-citation publication-type="journal"><article-title>Extracting tidy and user-friendly TSVs from SIDER 4.1</article-title> <string-name><given-names>Daniel S.</given-names> <surname>Himmelstein</surname></string-name> (<year>2016</year>) <source>Zenodo</source>. doi:<pub-id pub-id-type="doi">10.5281/zenodo.45521</pub-id></mixed-citation></ref>
<ref id="c73"><label>73.</label><mixed-citation publication-type="journal"><article-title>The Unified Medical Language System (UMLS): integrating biomedical terminology</article-title> <string-name><given-names>O.</given-names> <surname>Bodenreider</surname></string-name> (<year>2004</year>) <source>Nucleic Acids Research</source>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkh061</pub-id></mixed-citation></ref>
<ref id="c74"><label>74.</label><mixed-citation publication-type="journal"><article-title>Incorporating DrugCentral data in our network</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Oleg</surname> <given-names>Ursu</given-names></string-name> (<year>2016</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d186</pub-id></mixed-citation></ref>
<ref id="c75"><label>75.</label><mixed-citation publication-type="journal"><article-title>Entrez Gene: gene-centered information at NCBI</article-title> <string-name><given-names>D.</given-names> <surname>Maglott</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Ostell</surname></string-name>, <string-name><given-names>K. D.</given-names> <surname>Pruitt</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Tatusova</surname></string-name> (<year>2010</year>) <source>Nucleic Acids Research</source>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkq1237</pub-id></mixed-citation></ref>
<ref id="c76"><label>76.</label><mixed-citation publication-type="journal"><article-title>Using Entrez Gene as our gene vocabulary</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Casey</surname> <given-names>Greene</given-names></string-name>, <string-name><surname>Alexander</surname> <given-names>Pico</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d34</pub-id></mixed-citation></ref>
<ref id="c77"><label>77.</label><mixed-citation publication-type="journal"><article-title>Processed Entrez Gene datasets for humans v1.0</article-title> <string-name><given-names>Daniel S.</given-names> <surname>Himmelstein</surname></string-name> (<year>2016</year>) <source>Zenodo</source>. doi:<pub-id pub-id-type="doi">10.5281/zenodo.45524</pub-id></mixed-citation></ref>
<ref id="c78"><label>78.</label><mixed-citation publication-type="journal"><article-title>Uberon, an integrative multi-species anatomy ontology</article-title> <string-name><given-names>Christopher J</given-names> <surname>Mungall</surname></string-name>, <string-name><surname>Carlo</surname> <given-names>Torniai</given-names></string-name>, <string-name><given-names>Georgios V</given-names> <surname>Gkoutos</surname></string-name>, <string-name><given-names>Suzanna E</given-names> <surname>Lewis</surname></string-name>, <string-name><given-names>Melissa A</given-names> <surname>Haendel</surname></string-name> (<year>2012</year>) <source>Genome Biol</source>. doi:<pub-id pub-id-type="doi">10.1186/gb-2012-13-1-r5</pub-id></mixed-citation></ref>
<ref id="c79"><label>79.</label><mixed-citation publication-type="journal"><article-title>Tissue Node</article-title> <string-name><surname>Venkat</surname> <given-names>Malladi</given-names></string-name>, <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Chris</surname> <given-names>Mungall</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d41</pub-id></mixed-citation></ref>
<ref id="c80"><label>80.</label><mixed-citation publication-type="journal"><article-title>User-friendly anatomical structures data from the Uberon Ontology v1.0</article-title> <string-name><given-names>Daniel S.</given-names> <surname>Himmelstein</surname></string-name> (<year>2016</year>) <source>Zenodo</source>. doi:<pub-id pub-id-type="doi">10.5281/zenodo.45527</pub-id></mixed-citation></ref>
<ref id="c81"><label>81.</label><mixed-citation publication-type="journal"><article-title>WikiPathways: capturing the full diversity of pathway knowledge</article-title> <string-name><surname>Martina</surname> <given-names>Kutmon</given-names></string-name>, <string-name><surname>Anders</surname> <given-names>Riutta</given-names></string-name>, <string-name><surname>Nuno</surname> <given-names>Nunes</given-names></string-name>, <string-name><surname>Kristina</surname> <given-names>Hanspers</given-names></string-name>, <string-name><given-names>Egon L.</given-names> <surname>Willighagen</surname></string-name>, <string-name><surname>Anwesha</surname> <given-names>Bohler</given-names></string-name>, <string-name><surname>Jonathan</surname> <given-names>M&#x00E9;lius</given-names></string-name>, <string-name><surname>Andra</surname> <given-names>Waagmeester</given-names></string-name>, <string-name><given-names>Sravanthi R.</given-names> <surname>Sinha</surname></string-name>, <string-name><surname>Ryan</surname> <given-names>Miller</given-names></string-name>, <string-name><given-names>Susan L.</given-names> <surname>Coort</surname></string-name>, <string-name><surname>Elisa</surname> <given-names>Cirillo</given-names></string-name>, <string-name><surname>Bart</surname> <given-names>Smeets</given-names></string-name>, <string-name><given-names>Chris T.</given-names> <surname>Evelo</surname></string-name>, <string-name><given-names>Alexander R.</given-names> <surname>Pico</surname></string-name> (<year>2015</year>) <source>Nucleic Acids Res</source>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkv1024</pub-id></mixed-citation></ref>
<ref id="c82"><label>82.</label><mixed-citation publication-type="journal"><article-title>WikiPathways: Pathway Editing for the People</article-title> <string-name><given-names>Alexander R.</given-names> <surname>Pico</surname></string-name>, <string-name><surname>Thomas</surname> <given-names>Kelder</given-names></string-name>, <string-name><given-names>Martijn P.</given-names> <surname>van Iersel</surname></string-name>, <string-name><surname>Kristina</surname> <given-names>Hanspers</given-names></string-name>, <string-name><given-names>Bruce R.</given-names> <surname>Conklin</surname></string-name>, <string-name><surname>Chris</surname> <given-names>Evelo</given-names></string-name> (<year>2008</year>) <source>Plos Biol</source>. doi:<pub-id pub-id-type="doi">10.1371/journal.pbio.0060184</pub-id></mixed-citation></ref>
<ref id="c83"><label>83.</label><mixed-citation publication-type="journal"><article-title>The Reactome pathway Knowledgebase</article-title> <string-name><surname>Antonio</surname> <given-names>Fabregat</given-names></string-name>, <string-name><surname>Konstantinos</surname> <given-names>Sidiropoulos</given-names></string-name>, <string-name><surname>Phani</surname> <given-names>Garapati</given-names></string-name>, <string-name><surname>Marc</surname> <given-names>Gillespie</given-names></string-name>, <string-name><surname>Kerstin</surname> <given-names>Hausmann</given-names></string-name>, <string-name><surname>Robin</surname> <given-names>Haw</given-names></string-name>, <string-name><surname>Bijay</surname> <given-names>Jassal</given-names></string-name>, <string-name><surname>Steven</surname> <given-names>Jupe</given-names></string-name>, <string-name><surname>Florian</surname> <given-names>Korninger</given-names></string-name>, <string-name><surname>Sheldon</surname> <given-names>McKay</given-names></string-name>, <string-name><surname>Lisa</surname> <given-names>Matthews</given-names></string-name>, <string-name><surname>Bruce</surname> <given-names>May</given-names></string-name>, <string-name><surname>Marija</surname> <given-names>Milacic</given-names></string-name>, <string-name><surname>Karen</surname> <given-names>Rothfels</given-names></string-name>, <string-name><surname>Veronica</surname> <given-names>Shamovsky</given-names></string-name>, <string-name><surname>Marissa</surname> <given-names>Webber</given-names></string-name>, <string-name><surname>Joel</surname> <given-names>Weiser</given-names></string-name>, <string-name><surname>Mark</surname> <given-names>Williams</given-names></string-name>, <string-name><surname>Guanming</surname> <given-names>Wu</given-names></string-name>, <string-name><surname>Lincoln</surname> <given-names>Stein</given-names></string-name>, <string-name><surname>Henning</surname> <given-names>Hermjakob</given-names></string-name>, <string-name><surname>Peter</surname> <given-names>D&#x2019;Eustachio</given-names></string-name> (<year>2015</year>) <source>Nucleic Acids Res</source>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkv1351</pub-id></mixed-citation></ref>
<ref id="c84"><label>84.</label><mixed-citation publication-type="journal"><article-title>PID: the Pathway Interaction Database</article-title> <string-name><given-names>C. F.</given-names> <surname>Schaefer</surname></string-name>, <string-name><given-names>K.</given-names> <surname>Anthony</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Krupa</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Buchoff</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Day</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Hannay</surname></string-name>, <string-name><given-names>K. H.</given-names> <surname>Buetow</surname></string-name> (<year>2009</year>) <source>Nucleic Acids Research</source>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkn653</pub-id></mixed-citation></ref>
<ref id="c85"><label>85.</label><mixed-citation publication-type="journal"><article-title>Pathway Commons, a web resource for biological pathway data</article-title> <string-name><given-names>E. G.</given-names> <surname>Cerami</surname></string-name>, <string-name><given-names>B. E.</given-names> <surname>Gross</surname></string-name>, <string-name><given-names>E.</given-names> <surname>Demir</surname></string-name>, <string-name><given-names>I.</given-names> <surname>Rodchenkov</surname></string-name>, <string-name><given-names>O.</given-names> <surname>Babur</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Anwar</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Schultz</surname></string-name>, <string-name><given-names>G. D.</given-names> <surname>Bader</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Sander</surname></string-name> (<year>2010</year>) <source>Nucleic Acids Research</source> doi:<pub-id pub-id-type="doi">10.1093/nar/gkq1039</pub-id></mixed-citation></ref>
<ref id="c86"><label>86.</label><mixed-citation publication-type="journal"><article-title>Adding pathway resources to your network</article-title> <string-name><surname>Alexander</surname> <given-names>Pico</given-names></string-name>, <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name> (<year>2015</year>) <source>Thinklab</source> doi:<pub-id pub-id-type="doi">10.15363/thinklab.d72</pub-id></mixed-citation></ref>
<ref id="c87"><label>87.</label><mixed-citation publication-type="journal"><article-title>dhimmel/pathways v2.0: Compiling human pathway gene sets</article-title> <string-name><given-names>Daniel S.</given-names> <surname>Himmelstein</surname></string-name>, <string-name><given-names>Alexander R.</given-names> <surname>Pico</surname></string-name> (<year>2016</year>) <source>Zenodo</source>. doi:<pub-id pub-id-type="doi">10.5281/zenodo.48810</pub-id></mixed-citation></ref>
<ref id="c88"><label>88.</label><mixed-citation publication-type="journal"><article-title>Gene Ontology: tool for the unification of biology</article-title> <string-name><given-names>Michael</given-names> <surname>Ashburner</surname></string-name>, <string-name><given-names>Catherine A.</given-names> <surname>Ball</surname></string-name>, <string-name><given-names>Judith A.</given-names> <surname>Blake</surname></string-name>, <string-name><given-names>David</given-names> <surname>Botstein</surname></string-name>, <string-name><given-names>Heather</given-names> <surname>Butler</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Michael Cherry</surname></string-name>, <string-name><given-names>Allan P.</given-names> <surname>Davis</surname></string-name>, <string-name><given-names>Kara</given-names> <surname>Dolinski</surname></string-name>, <string-name><given-names>Selina S.</given-names> <surname>Dwight</surname></string-name>, <string-name><given-names>Janan T.</given-names> <surname>Eppig</surname></string-name>, <string-name><given-names>Midori A.</given-names> <surname>Harris</surname></string-name>, <string-name><given-names>David P.</given-names> <surname>Hill</surname></string-name>, <string-name><surname>Laurie</surname> <given-names>Issel-Tarver</given-names></string-name>, <string-name><surname>Andrew</surname> <given-names>Kasarskis</given-names></string-name>, <string-name><surname>Suzanna</surname> <given-names>Lewis</given-names></string-name>, <string-name><given-names>John C.</given-names> <surname>Matese</surname></string-name>, <string-name><given-names>Joel E.</given-names> <surname>Richardson</surname></string-name>, <string-name><surname>Martin</surname> <given-names>Ringwald</given-names></string-name>, <string-name><given-names>Gerald M.</given-names> <surname>Rubin</surname></string-name>, <string-name><surname>Gavin</surname> <given-names>Sherlock</given-names></string-name> (<year>2000</year>) <source>Nat Genet</source>. doi:<pub-id pub-id-type="doi">10.1038/75556</pub-id></mixed-citation></ref>
<ref id="c89"><label>89.</label><mixed-citation publication-type="journal"><article-title>Disease Ontology feature requests</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d68</pub-id></mixed-citation></ref>
<ref id="c90"><label>90.</label><mixed-citation publication-type="journal"><article-title>Chemical databases: curation or integration by user-defined equivalence?</article-title> <string-name><surname>Anne</surname> <given-names>Hersey</given-names></string-name>, <string-name><surname>Jon</surname> <given-names>Chambers</given-names></string-name>, <string-name><surname>Louisa</surname> <given-names>Bellis</given-names></string-name>, <string-name><given-names>A.</given-names> <surname>Patr&#x00ED;cia Bento</surname></string-name>, <string-name><surname>Anna</surname> <given-names>Gaulton</given-names></string-name>, <string-name><given-names>John P.</given-names> <surname>Overington</surname></string-name> (<year>2015</year>) <source>Drug Discovery Today: Technologies</source>. doi:<pub-id pub-id-type="doi">10.1016/j.ddtec.2015.01.005</pub-id></mixed-citation></ref>
<ref id="c91"><label>91.</label><mixed-citation publication-type="journal"><article-title>UniChem: a unified chemical structure cross-referencing and identifier tracking system</article-title> <string-name><surname>Jon</surname> <given-names>Chambers</given-names></string-name>, <string-name><surname>Mark</surname> <given-names>Davies</given-names></string-name>, <string-name><surname>Anna</surname> <given-names>Gaulton</given-names></string-name>, <string-name><surname>Anne</surname> <given-names>Hersey</given-names></string-name>, <string-name><surname>Sameer</surname> <given-names>Velankar</given-names></string-name>, <string-name><surname>Robert</surname> <given-names>Petryszak</given-names></string-name>, <string-name><surname>Janna</surname> <given-names>Hastings</given-names></string-name>, <string-name><surname>Louisa</surname> <given-names>Bellis</given-names></string-name>, <string-name><surname>Shaun</surname> <given-names>McGlinchey</given-names></string-name>, <string-name><given-names>John P</given-names> <surname>Overington</surname></string-name> (<year>2013</year>) <source>Journal of Cheminformatics</source>. doi:<pub-id pub-id-type="doi">10.1186/1758-2946-5-3</pub-id></mixed-citation></ref>
<ref id="c92"><label>92.</label><mixed-citation publication-type="journal"><article-title>UniChem: extension of InChI-based compound mapping to salt, connectivity and stereochemistry layers</article-title> <string-name><surname>Jon</surname> <given-names>Chambers</given-names></string-name>, <string-name><surname>Mark</surname> <given-names>Davies</given-names></string-name>, <string-name><surname>Anna</surname> <given-names>Gaulton</given-names></string-name>, <string-name><surname>George</surname> <given-names>Papadatos</given-names></string-name>, <string-name><surname>Anne</surname> <given-names>Hersey</given-names></string-name>, <string-name><given-names>John P</given-names> <surname>Overington</surname></string-name> (<year>2014</year>) <source>Journal of Cheminformatics</source>. doi:<pub-id pub-id-type="doi">10.1186/s13321-014-0043-5</pub-id></mixed-citation></ref>
<ref id="c93"><label>93.</label><mixed-citation publication-type="journal"><article-title>InChI - the worldwide chemical structure identifier standard</article-title> <string-name><surname>Stephen</surname> <given-names>Heller</given-names></string-name>, <string-name><surname>Alan</surname> <given-names>McNaught</given-names></string-name>, <string-name><surname>Stephen</surname> <given-names>Stein</given-names></string-name>, <string-name><surname>Dmitrii</surname> <given-names>Tchekhovskoi</given-names></string-name>, <string-name><surname>Igor</surname> <given-names>Pletnev</given-names></string-name> (<year>2013</year>) <source>Journal of Cheminformatics</source>. doi:<pub-id pub-id-type="doi">10.1186/1758-2946-5-7</pub-id></mixed-citation></ref>
<ref id="c94"><label>94.</label><mixed-citation publication-type="journal"><article-title>dhimmel/bgee v1.0: Anatomy-specific gene expression in humans from Bgee</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Frederic</surname> <given-names>Bastian</given-names></string-name>, <string-name><surname>Sergio</surname> <given-names>Baranzini</given-names></string-name> (<year>2016</year>) <source>Zenodo</source>. doi:<pub-id pub-id-type="doi">10.5281/zenodo.47157</pub-id></mixed-citation></ref>
<ref id="c95"><label>95.</label><mixed-citation publication-type="journal"><article-title>Processing Bgee for tissue-specific gene presence and over/under-expression</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Frederic</surname> <given-names>Bastian</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d124</pub-id></mixed-citation></ref>
<ref id="c96"><label>96.</label><mixed-citation publication-type="journal"><article-title>Tissue-specific gene expression resources</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Frederic</surname> <given-names>Bastian</given-names></string-name> (<year>2015</year>) <source>Thinklab</source> doi:<pub-id pub-id-type="doi">10.15363/thinklab.d81</pub-id></mixed-citation></ref>
<ref id="c97"><label>97.</label><mixed-citation publication-type="journal"><article-title>Bgee: Integrating and Comparing Heterogeneous Transcriptome Data Among Species</article-title> <string-name><surname>Frederic</surname> <given-names>Bastian</given-names></string-name>, <string-name><surname>Gilles</surname> <given-names>Parmentier</given-names></string-name>, <string-name><surname>Julien</surname> <given-names>Roux</given-names></string-name>, <string-name><surname>Sebastien</surname> <given-names>Moretti</given-names></string-name>, <string-name><surname>Vincent</surname> <given-names>Laudet</given-names></string-name>, <string-name><surname>Marc</surname> <given-names>Robinson-Rechavi</given-names></string-name> (<year>2008</year>) <source>Data Integration in the Life Sciences</source>. doi:<pub-id pub-id-type="doi">10.1007/978-3-540-69828-9_12</pub-id></mixed-citation></ref>
<ref id="c98"><label>98.</label><mixed-citation publication-type="journal"><article-title>Comprehensive comparison of large-scale tissue expression datasets</article-title> <string-name><surname>Alberto</surname> <given-names>Santos</given-names></string-name>, <string-name><surname>Kalliopi</surname> <given-names>Tsafou</given-names></string-name>, <string-name><surname>Christian</surname> <given-names>Stolte</given-names></string-name>, <string-name><surname>Sune</surname> <given-names>Pletscher-Frankild</given-names></string-name>, <string-name><given-names>Se&#x00E1;n I.</given-names> <surname>O&#x2019;Donoghue</surname></string-name>, <string-name><surname>Lars</surname> <given-names>Juhl Jensen</given-names></string-name> (<year>2015</year>) <source>PeerJ</source>. doi:<pub-id pub-id-type="doi">10.7717/peerj.1054</pub-id></mixed-citation></ref>
<ref id="c99"><label>99.</label><mixed-citation publication-type="journal"><article-title>Gene&#x2013;Tissue relationships from the TISSUES database</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Lars</surname> <given-names>Juhl Jensen</given-names></string-name> (<year>2015</year>) <source>Zenodo</source>. doi:<pub-id pub-id-type="doi">10.5281/zenodo.27244</pub-id></mixed-citation></ref>
<ref id="c100"><label>100.</label><mixed-citation publication-type="journal"><article-title>The TISSUES resource for the tissue-specificity of genes</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Lars</surname> <given-names>Juhl Jensen</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d91</pub-id></mixed-citation></ref>
<ref id="c101"><label>101.</label><mixed-citation publication-type="journal"><article-title>BindingDB: A Web-Accessible Molecular Recognition Database</article-title> <string-name><surname>Xi</surname> <given-names>Chen</given-names></string-name>, <string-name><surname>Ming</surname> <given-names>Liu</given-names></string-name>, <string-name><surname>Michael</surname> <given-names>Gilson</given-names></string-name> (<year>2001</year>) <source>Combinatorial Chemistry &#x0026; High Throughput Screening</source>. doi:<pub-id pub-id-type="doi">10.2174/1386207013330670</pub-id></mixed-citation></ref>
<ref id="c102"><label>102.</label><mixed-citation publication-type="journal"><article-title>BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology</article-title> <string-name><given-names>Michael K.</given-names> <surname>Gilson</surname></string-name>, <string-name><surname>Tiqing</surname> <given-names>Liu</given-names></string-name>, <string-name><surname>Michael</surname> <given-names>Baitaluk</given-names></string-name>, <string-name><surname>George</surname> <given-names>Nicola</given-names></string-name>, <string-name><surname>Linda</surname> <given-names>Hwang</given-names></string-name>, <string-name><surname>Jenny</surname> <given-names>Chong</given-names></string-name> (<year>2015</year>) <source>Nucleic Acids Res</source>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkv1072</pub-id></mixed-citation></ref>
<ref id="c103"><label>103.</label><mixed-citation publication-type="journal"><article-title>DrugBank: a comprehensive resource for in silico drug discovery and exploration</article-title> <string-name><given-names>D. S.</given-names> <surname>Wishart</surname></string-name> (<year>2006</year>) <source>Nucleic Acids Research</source>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkj067</pub-id></mixed-citation></ref>
<ref id="c104"><label>104.</label><mixed-citation publication-type="journal"><article-title>Integrating drug target information from BindingDB</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Mike</surname> <given-names>Gilson</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d53</pub-id></mixed-citation></ref>
<ref id="c105"><label>105.</label><mixed-citation publication-type="journal"><article-title>Processing the October 2015 BindingDB</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Michael</surname> <given-names>Gilson</given-names></string-name>, <string-name><surname>Sergio</surname> <given-names>Baranzini</given-names></string-name> (<year>2015</year>) <source>Zenodo</source>. doi:<pub-id pub-id-type="doi">10.5281/zenodo.33987</pub-id></mixed-citation></ref>
<ref id="c106"><label>106.</label><mixed-citation publication-type="journal"><article-title>Protein (target, carrier, transporter, and enzyme) interactions in DrugBank</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Sabrina</surname> <given-names>Chen</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d65</pub-id></mixed-citation></ref>
<ref id="c107"><label>107.</label><mixed-citation publication-type="journal"><article-title>Calculating molecular similarities between DrugBank compounds</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Sabrina</surname> <given-names>Chen</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d70</pub-id></mixed-citation></ref>
<ref id="c108"><label>108.</label><mixed-citation publication-type="journal"><article-title>Pairwise molecular similarities between DrugBank compounds</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Leo</surname> <given-names>Brueggeman</given-names></string-name>, <string-name><surname>Sergio</surname> <given-names>Baranzini</given-names></string-name> (<year>2015</year>) <source>Figshare</source>. doi:<pub-id pub-id-type="doi">10.6084/m9.figshare.1418386</pub-id></mixed-citation></ref>
<ref id="c109"><label>109.</label><mixed-citation publication-type="journal"><article-title>Measures of the Amount of Ecologic Association Between Species</article-title> <string-name><given-names>Lee R.</given-names> <surname>Dice</surname></string-name> (<year>1945</year>) <source>Ecology</source>. doi:<pub-id pub-id-type="doi">10.2307/1932409</pub-id></mixed-citation></ref>
<ref id="c110"><label>110.</label><mixed-citation publication-type="journal"><article-title>Extended-Connectivity Fingerprints</article-title> <string-name><surname>David</surname> <given-names>Rogers</given-names></string-name>, <string-name><surname>Mathew</surname> <given-names>Hahn</given-names></string-name> (<year>2010</year>) <source>Journal of Chemical Information and Modeling</source>. doi:<pub-id pub-id-type="doi">10.1021/ci100050t</pub-id></mixed-citation></ref>
<ref id="c111"><label>111.</label><mixed-citation publication-type="journal"><article-title>The Generation of a Unique Machine Description for Chemical Structures-A Technique Developed at Chemical Abstracts Service</article-title>. <string-name><given-names>H. L.</given-names> <surname>Morgan</surname></string-name> (<year>1965</year>) <source>J. Chem. Doc</source>. doi:<pub-id pub-id-type="doi">10.1021/c160017a018</pub-id></mixed-citation></ref>
<ref id="c112"><label>112.</label><mixed-citation publication-type="journal"><article-title>dhimmel/gwas-catalog v1.0: Extracting gene&#x00E2;disease associations from the GWAS Catalog</article-title> <string-name><given-names>Daniel S.</given-names> <surname>Himmelstein</surname></string-name>, <string-name><given-names>Sergio E.</given-names> <surname>Baranzini</surname></string-name> (<year>2016</year>) <source>Zenodo</source>. doi:<pub-id pub-id-type="doi">10.5281/zenodo.48428</pub-id></mixed-citation></ref>
<ref id="c113"><label>113.</label><mixed-citation publication-type="journal"><article-title>Processing the DISEASES resource for disease&#x2013;gene relationships</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Lars</surname> <given-names>Juhl Jensen</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d106</pub-id></mixed-citation></ref>
<ref id="c114"><label>114.</label><mixed-citation publication-type="journal"><article-title>dhimmel/diseases v1.0: Processing the DISEASES database of gene&#x00E2;disease associations</article-title> <string-name><given-names>Daniel S.</given-names> <surname>Himmelstein</surname></string-name>, <string-name><surname>Lars</surname> <given-names>Juhl Jensen</given-names></string-name> (<year>2016</year>) <source>Zenodo</source>. doi:<pub-id pub-id-type="doi">10.5281/zenodo.48425</pub-id></mixed-citation></ref>
<ref id="c115"><label>115.</label><mixed-citation publication-type="journal"><article-title>Processing DisGeNET for disease-gene relationships</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>janet</surname> <given-names>pi&#x00F1;ero</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d105</pub-id></mixed-citation></ref>
<ref id="c116"><label>116.</label><mixed-citation publication-type="journal"><article-title>dhimmel/disgenet v1.0: Processing the DisGeNET database of gene&#x00E2;disease associations</article-title> <string-name><given-names>Daniel S.</given-names> <surname>Himmelstein</surname></string-name>, <string-name><surname>Janet</surname> <given-names>Pi&#x0102;&#x0105;ero</given-names></string-name> (<year>2016</year>) <source>Zenodo</source>. doi:<pub-id pub-id-type="doi">10.5281/zenodo.48426</pub-id></mixed-citation></ref>
<ref id="c117"><label>117.</label><mixed-citation publication-type="journal"><article-title>Functional disease annotations for genes using DOAF</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d94</pub-id></mixed-citation></ref>
<ref id="c118"><label>118.</label><mixed-citation publication-type="journal"><article-title>dhimmel/doaf v1.0: Processing the DOAF database of gene&#x00E2;disease associations</article-title> <string-name><given-names>Daniel S.</given-names> <surname>Himmelstein</surname></string-name> (<year>2016</year>) <source>Zenodo</source>. doi:<pub-id pub-id-type="doi">10.5281/zenodo.48427</pub-id></mixed-citation></ref>
<ref id="c119"><label>119.</label><mixed-citation publication-type="journal"><article-title>The NHGRI GWAS Catalog, a curated resource of SNP-trait associations</article-title> <string-name><given-names>D.</given-names> <surname>Welter</surname></string-name>, <string-name><given-names>J.</given-names> <surname>MacArthur</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Morales</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Burdett</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Hall</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Junkins</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Klemm</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Flicek</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Manolio</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Hindorff</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Parkinson</surname></string-name> (<year>2013</year>) <source>Nucleic Acids Research</source>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkt1229</pub-id></mixed-citation></ref>
<ref id="c120"><label>120.</label><mixed-citation publication-type="journal"><article-title>Extracting disease-gene associations from the GWAS Catalog</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d80</pub-id></mixed-citation></ref>
<ref id="c121"><label>121.</label><mixed-citation publication-type="journal"><article-title>Calculating genomic windows for GWAS lead SNPs</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Marina</surname> <given-names>Sirota</given-names></string-name>, <string-name><surname>Greg</surname> <given-names>Way</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d71</pub-id></mixed-citation></ref>
<ref id="c122"><label>122.</label><mixed-citation publication-type="journal"><article-title>DISEASES: Text mining and data integration of disease&#x2013;gene associations</article-title> <string-name><surname>Sune</surname> <given-names>Pletscher-Frankild</given-names></string-name>, <string-name><surname>Albert</surname> <given-names>Pallej&#x00E0;</given-names></string-name>, <string-name><surname>Kalliopi</surname> <given-names>Tsafou</given-names></string-name>, <string-name><given-names>Janos X.</given-names> <surname>Binder</surname></string-name>, <string-name><surname>Lars</surname> <given-names>Juhl Jensen</given-names></string-name> (<year>2015</year>) <source>Methods</source>. doi:<pub-id pub-id-type="doi">10.1016/j.ymeth.2014.11.020</pub-id></mixed-citation></ref>
<ref id="c123"><label>123.</label><mixed-citation publication-type="journal"><article-title>DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes</article-title> <string-name><given-names>J.</given-names> <surname>Pinero</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Queralt-Rosinach</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Bravo</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Deu-Pons</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Bauer-Mehren</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Baron</surname></string-name>, <string-name><given-names>F.</given-names> <surname>Sanz</surname></string-name>, <string-name><given-names>L. I.</given-names> <surname>Furlong</surname></string-name> (<year>2015</year>) <source>Database</source>. doi:<pub-id pub-id-type="doi">10.1093/database/bav028</pub-id></mixed-citation></ref>
<ref id="c124"><label>124.</label><mixed-citation publication-type="journal"><article-title>A Framework for Annotating Human Genome in Disease Context</article-title> <string-name><surname>Wei</surname> <given-names>Xu</given-names></string-name>, <string-name><surname>Huisong</surname> <given-names>Wang</given-names></string-name>, <string-name><surname>Wenqing</surname> <given-names>Cheng</given-names></string-name>, <string-name><surname>Dong</surname> <given-names>Fu</given-names></string-name>, <string-name><surname>Tian</surname> <given-names>Xia</given-names></string-name>, <string-name><given-names>Warren A.</given-names> <surname>Kibbe</surname></string-name>, <string-name><given-names>Simon M.</given-names> <surname>Lin</surname></string-name> (<year>2012</year>) <source>PLoS ONE</source>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0049686</pub-id></mixed-citation></ref>
<ref id="c125"><label>125.</label><mixed-citation publication-type="journal"><article-title>STARGEO: expression signatures for disease using crowdsourced GEO annotation</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Frederic</surname> <given-names>Bastian</given-names></string-name>, <string-name><surname>Dexter</surname> <given-names>Hadley</given-names></string-name>, <string-name><surname>Casey</surname> <given-names>Greene</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d96</pub-id></mixed-citation></ref>
<ref id="c126"><label>126.</label><mixed-citation publication-type="journal"><article-title>dhimmel/stargeo v1.0: differentially expressed genes for 48 diseases from STARGEO</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Dexter</surname> <given-names>Hadley</given-names></string-name>, <string-name><surname>Alexander</surname> <given-names>Schepanovski</given-names></string-name> (<year>2016</year>) <source>Zenodo</source>. doi:<pub-id pub-id-type="doi">10.5281/zenodo.46866</pub-id></mixed-citation></ref>
<ref id="c127"><label>127.</label><mixed-citation publication-type="journal"><article-title>dhimmel/medline v1.0: Disease, symptom, and anatomy cooccurence in MEDLINE</article-title> <string-name><given-names>Daniel S.</given-names> <surname>Himmelstein</surname></string-name> (<year>2016</year>) <source>Zenodo</source>. doi:<pub-id pub-id-type="doi">10.5281/zenodo.48445</pub-id></mixed-citation></ref>
<ref id="c128"><label>128.</label><mixed-citation publication-type="journal"><article-title>Disease similarity from MEDLINE topic cooccurrence</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d93</pub-id></mixed-citation></ref>
<ref id="c129"><label>129.</label><mixed-citation publication-type="journal"><article-title>On the Interpretation of &#x03C7; 2 from Contingency Tables, and the Calculation of P</article-title> <string-name><given-names>R. A.</given-names> <surname>Fisher</surname></string-name> (<year>1922</year>) <source>Journal of the Royal Statistical Society</source>. doi:<pub-id pub-id-type="doi">10.2307/2340521</pub-id></mixed-citation></ref>
<ref id="c130"><label>130.</label><mixed-citation publication-type="journal"><article-title>Evolutionary Signatures amongst Disease Genes Permit Novel Methods for Gene Prioritization and Construction of Informative Gene-Based Networks</article-title> <string-name><surname>Nolan</surname> <given-names>Priedigkeit</given-names></string-name>, <string-name><surname>Nicholas</surname> <given-names>Wolfe</given-names></string-name>, <string-name><given-names>Nathan L.</given-names> <surname>Clark</surname></string-name> (<year>2015</year>) <source>PLOS Genetics</source>. doi:<pub-id pub-id-type="doi">10.1371/journal.pgen.1004967</pub-id></mixed-citation></ref>
<ref id="c131"><label>131.</label><mixed-citation publication-type="journal"><article-title>Selecting informative ERC (evolutionary rate covariation) values between genes</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Raghavendran</surname> <given-names>Partha</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d57</pub-id></mixed-citation></ref>
<ref id="c132"><label>132.</label><mixed-citation publication-type="journal"><article-title>dhimmel/erc v1.0: Processing human evolutionary rate covaration data</article-title> <string-name><given-names>Daniel S.</given-names> <surname>Himmelstein</surname></string-name> (<year>2016</year>) <source>Zenodo</source>. doi:<pub-id pub-id-type="doi">10.5281/zenodo.48444</pub-id></mixed-citation></ref>
<ref id="c133"><label>133.</label><mixed-citation publication-type="journal"><article-title>Creating a catalog of protein interactions</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Dexter</surname> <given-names>Hadley</given-names></string-name>, <string-name><surname>Alexey</surname> <given-names>Strokach</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d85</pub-id></mixed-citation></ref>
<ref id="c134"><label>134.</label><mixed-citation publication-type="journal"><article-title>dhimmel/ppi v1.0: Compiling a human protein interaction catalog</article-title> <string-name><given-names>Daniel S.</given-names> <surname>Himmelstein</surname></string-name>, <string-name><given-names>Sergio E.</given-names> <surname>Baranzini</surname></string-name> (<year>2016</year>) <source>Zenodo</source>. doi:<pub-id pub-id-type="doi">10.5281/zenodo.48443</pub-id></mixed-citation></ref>
<ref id="c135"><label>135.</label><mixed-citation publication-type="journal"><article-title>Towards a proteome-scale map of the human protein&#x2013;protein interaction network</article-title> <string-name><surname>Jean-Fran&#x00E7;ois</surname> <given-names>Rual</given-names></string-name>, <string-name><surname>Kavitha</surname> <given-names>Venkatesan</given-names></string-name>, <string-name><surname>Tong</surname> <given-names>Hao</given-names></string-name>, <string-name><surname>Tomoko</surname> <given-names>Hirozane-Kishikawa</given-names></string-name>, <string-name><surname>Am&#x00E9;lie</surname> <given-names>Dricot</given-names></string-name>, <string-name><surname>Ning</surname> <given-names>Li</given-names></string-name>, <string-name><given-names>Gabriel F.</given-names> <surname>Berriz</surname></string-name>, <string-name><given-names>Francis D.</given-names> <surname>Gibbons</surname></string-name>, <string-name><surname>Matija</surname> <given-names>Dreze</given-names></string-name>, <string-name><surname>Nono</surname> <given-names>Ayivi-Guedehoussou</given-names></string-name>, <string-name><surname>Niels</surname> <given-names>Klitgord</given-names></string-name>, <string-name><surname>Christophe</surname> <given-names>Simon</given-names></string-name>, <string-name><surname>Mike</surname> <given-names>Boxem</given-names></string-name>, <string-name><surname>Stuart</surname> <given-names>Milstein</given-names></string-name>, <string-name><surname>Jennifer</surname> <given-names>Rosenberg</given-names></string-name>, <string-name><given-names>Debra S.</given-names> <surname>Goldberg</surname></string-name>, <string-name><given-names>Lan V.</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>Sharyl L.</given-names> <surname>Wong</surname></string-name>, <string-name><surname>Giovanni</surname> <given-names>Franklin</given-names></string-name>, <string-name><surname>Siming</surname> <given-names>Li</given-names></string-name>, <string-name><given-names>Joanna S.</given-names> <surname>Albala</surname></string-name>, <string-name><surname>Janghoo</surname> <given-names>Lim</given-names></string-name>, <string-name><surname>Carlene</surname> <given-names>Fraughton</given-names></string-name>, <string-name><surname>Estelle</surname> <given-names>Llamosas</given-names></string-name>, <string-name><surname>Sebiha</surname> <given-names>Cevik</given-names></string-name>, <string-name><surname>Camille</surname> <given-names>Bex</given-names></string-name>, <string-name><surname>Philippe</surname> <given-names>Lamesch</given-names></string-name>, <string-name><given-names>Robert S.</given-names> <surname>Sikorski</surname></string-name>, <string-name><surname>Jean</surname> <given-names>Vandenhaute</given-names></string-name>, <string-name><given-names>Huda Y.</given-names> <surname>Zoghbi</surname></string-name>, <string-name><surname>Alex</surname> <given-names>Smolyar</given-names></string-name>, <string-name><surname>Stephanie</surname> <given-names>Bosak</given-names></string-name>, <string-name><surname>Reynaldo</surname> <given-names>Sequerra</given-names></string-name>, <string-name><surname>Lynn</surname> <given-names>Doucette-Stamm</given-names></string-name>, <string-name><given-names>Michael E.</given-names> <surname>Cusick</surname></string-name>, <string-name><given-names>David E.</given-names> <surname>Hill</surname></string-name>, <string-name><given-names>Frederick P.</given-names> <surname>Roth</surname></string-name>, <string-name><surname>Marc</surname> <given-names>Vidal</given-names></string-name> (<year>2005</year>) <source>Nature</source>. doi:<pub-id pub-id-type="doi">10.1038/nature04209</pub-id></mixed-citation></ref>
<ref id="c136"><label>136.</label><mixed-citation publication-type="journal"><article-title>An empirical framework for binary interactome mapping</article-title> <string-name><surname>Kavitha</surname> <given-names>Venkatesan</given-names></string-name>, <string-name><surname>Jean-Fran&#x00E7;ois</surname> <given-names>Rual</given-names></string-name>, <string-name><surname>Alexei</surname> <given-names>Vazquez</given-names></string-name>, <string-name><surname>Ulrich</surname> <given-names>Stelzl</given-names></string-name>, <string-name><surname>Irma</surname> <given-names>Lemmens</given-names></string-name>, <string-name><surname>Tomoko</surname> <given-names>Hirozane-Kishikawa</given-names></string-name>, <string-name><surname>Tong</surname> <given-names>Hao</given-names></string-name>, <string-name><surname>Martina</surname> <given-names>Zenkner</given-names></string-name>, <string-name><surname>Xiaofeng</surname> <given-names>Xin</given-names></string-name>, <string-name><surname>Kwang-Il</surname> <given-names>Goh</given-names></string-name>, <string-name><surname>Muhammed</surname> <given-names>A Yildirim</given-names></string-name>, <string-name><surname>Nicolas</surname> <given-names>Simonis</given-names></string-name>, <string-name><surname>Kathrin</surname> <given-names>Heinzmann</given-names></string-name>, <string-name><surname>Fana</surname> <given-names>Gebreab</given-names></string-name>, <string-name><given-names>Julie M</given-names> <surname>Sahalie</surname></string-name>, <string-name><surname>Sebiha</surname> <given-names>Cevik</given-names></string-name>, <string-name><surname>Christophe</surname> <given-names>Simon</given-names></string-name>, <string-name><given-names>Anne-Sophie de</given-names> <surname>Smet</surname></string-name>, <string-name><surname>Elizabeth</surname> <given-names>Dann</given-names></string-name>, <string-name><surname>Alex</surname> <given-names>Smolyar</given-names></string-name>, <string-name><surname>Arunachalam</surname> <given-names>Vinayagam</given-names></string-name>, <string-name><surname>Haiyuan</surname> <given-names>Yu</given-names></string-name>, <string-name><surname>David</surname> <given-names>Szeto</given-names></string-name>, <string-name><surname>Heather</surname> <given-names>Borick</given-names></string-name>, <string-name><surname>Am&#x00E9;lie</surname> <given-names>Dricot</given-names></string-name>, <string-name><surname>Niels</surname> <given-names>Klitgord</given-names></string-name>, <string-name><given-names>Ryan R</given-names> <surname>Murray</surname></string-name>, <string-name><surname>Chenwei</surname> <given-names>Lin</given-names></string-name>, <string-name><surname>Maciej</surname> <given-names>Lalowski</given-names></string-name>, <string-name><surname>Jan</surname> <given-names>Timm</given-names></string-name>, <string-name><surname>Kirstin</surname> <given-names>Rau</given-names></string-name>, <string-name><surname>Charles</surname> <given-names>Boone</given-names></string-name>, <string-name><surname>Pascal</surname> <given-names>Braun</given-names></string-name>, <string-name><given-names>Michael E</given-names> <surname>Cusick</surname></string-name>, <string-name><given-names>Frederick P</given-names> <surname>Roth</surname></string-name>, <string-name><given-names>David E</given-names> <surname>Hill</surname></string-name>, <string-name><surname>Jan</surname> <given-names>Tavernier</given-names></string-name>, <string-name><given-names>Erich E</given-names> <surname>Wanker</surname></string-name>, <string-name><surname>Albert-L&#x00E1;szl&#x00F3;</surname> <given-names>Barab&#x00E1;si</given-names></string-name>, <string-name><surname>Marc</surname> <given-names>Vidal</given-names></string-name> (<year>2008</year>) <source>Nat Meth</source>. doi:<pub-id pub-id-type="doi">10.1038/nmeth.1280</pub-id></mixed-citation></ref>
<ref id="c137"><label>137.</label><mixed-citation publication-type="journal"><article-title>Next-generation sequencing to generate interactome datasets</article-title> <string-name><surname>Haiyuan</surname> <given-names>Yu</given-names></string-name>, <string-name><surname>Leah</surname> <given-names>Tardivo</given-names></string-name>, <string-name><surname>Stanley</surname> <given-names>Tam</given-names></string-name>, <string-name><surname>Evan</surname> <given-names>Weiner</given-names></string-name>, <string-name><surname>Fana</surname> <given-names>Gebreab</given-names></string-name>, <string-name><surname>Changyu</surname> <given-names>Fan</given-names></string-name>, <string-name><surname>Nenad</surname> <given-names>Svrzikapa</given-names></string-name>, <string-name><surname>Tomoko</surname> <given-names>Hirozane-Kishikawa</given-names></string-name>, <string-name><surname>Edward</surname> <given-names>Rietman</given-names></string-name>, <string-name><surname>Xinping</surname> <given-names>Yang</given-names></string-name>, <string-name><surname>Julie</surname> <given-names>Sahalie</given-names></string-name>, <string-name><surname>Kourosh</surname> <given-names>Salehi-Ashtiani</given-names></string-name>, <string-name><surname>Tong</surname> <given-names>Hao</given-names></string-name>, <string-name><surname>Michael E</surname> <given-names>Cusick</given-names></string-name>, <string-name><given-names>David E</given-names> <surname>Hill</surname></string-name>, <string-name><given-names>Frederick P</given-names> <surname>Roth</surname></string-name>, <string-name><surname>Pascal</surname> <given-names>Braun</given-names></string-name>, <string-name><surname>Marc</surname> <given-names>Vidal</given-names></string-name> (<year>2011</year>) <source>Nat Meth</source>. doi:<pub-id pub-id-type="doi">10.1038/nmeth.1597</pub-id></mixed-citation></ref>
<ref id="c138"><label>138.</label><mixed-citation publication-type="journal"><article-title>A Proteome-Scale Map of the Human Interactome Network</article-title> <string-name><surname>Thomas</surname> <given-names>Rolland</given-names></string-name>, <string-name><surname>Murat</surname> <given-names>Ta&#x015F;an</given-names></string-name>, <string-name><surname>Benoit</surname> <given-names>Charloteaux</given-names></string-name>, <string-name><given-names>Samuel J.</given-names> <surname>Pevzner</surname></string-name>, <string-name><surname>Quan</surname> <given-names>Zhong</given-names></string-name>, <string-name><surname>Nidhi</surname> <given-names>Sahni</given-names></string-name>, <string-name><surname>Song</surname> <given-names>Yi</given-names></string-name>, <string-name><surname>Irma</surname> <given-names>Lemmens</given-names></string-name>, <string-name><surname>Celia</surname> <given-names>Fontanillo</given-names></string-name>, <string-name><surname>Roberto</surname> <given-names>Mosca</given-names></string-name>, <string-name><surname>Atanas</surname> <given-names>Kamburov</given-names></string-name>, <string-name><given-names>Susan D.</given-names> <surname>Ghiassian</surname></string-name>, <string-name><surname>Xinping</surname> <given-names>Yang</given-names></string-name>, <string-name><surname>Lila</surname> <given-names>Ghamsari</given-names></string-name>, <string-name><surname>Dawit</surname> <given-names>Balcha</given-names></string-name>, <string-name><given-names>Bridget E.</given-names> <surname>Begg</surname></string-name>, <string-name><surname>Pascal</surname> <given-names>Braun</given-names></string-name>, <string-name><surname>Marc</surname> <given-names>Brehme</given-names></string-name>, <string-name><given-names>Martin P.</given-names> <surname>Broly</surname></string-name>, <string-name><surname>Anne-Ruxandra</surname> <given-names>Carvunis</given-names></string-name>, <string-name><surname>Dan</surname> <given-names>Convery-Zupan</given-names></string-name>, <string-name><surname>Roser</surname> <given-names>Corominas</given-names></string-name>, <string-name><surname>Jasmin</surname> <given-names>Coulombe-Huntington</given-names></string-name>, <string-name><surname>Elizabeth</surname> <given-names>Dann</given-names></string-name>, <string-name><surname>Matija</surname> <given-names>Dreze</given-names></string-name>, <string-name><surname>Am&#x00E9;lie</surname> <given-names>Dricot</given-names></string-name>, <string-name><surname>Changyu</surname> <given-names>Fan</given-names></string-name>, <string-name><surname>Eric</surname> <given-names>Franzosa</given-names></string-name>, <string-name><surname>Fana</surname> <given-names>Gebreab</given-names></string-name>, <string-name><given-names>Bryan J.</given-names> <surname>Gutierrez</surname></string-name>, <string-name><given-names>Madeleine F.</given-names> <surname>Hardy</surname></string-name>, <string-name><surname>Mike</surname> <given-names>Jin</given-names></string-name>, <string-name><surname>Shuli</surname> <given-names>Kang</given-names></string-name>, <string-name><surname>Ruth</surname> <given-names>Kiros</given-names></string-name>, <string-name><surname>Guan</surname> <given-names>Ning Lin</given-names></string-name>, <string-name><surname>Katja</surname> <given-names>Luck</given-names></string-name>, <string-name><surname>Andrew</surname> <given-names>MacWilliams</given-names></string-name>, <string-name><surname>J&#x00F6;rg</surname> <given-names>Menche</given-names></string-name>, <string-name><given-names>Ryan R.</given-names> <surname>Murray</surname></string-name>, <string-name><surname>Alexandre</surname> <given-names>Palagi</given-names></string-name>, <string-name><given-names>Matthew M.</given-names> <surname>Poulin</surname></string-name>, <string-name><surname>Xavier</surname> <given-names>Rambout</given-names></string-name>, <string-name><surname>John</surname> <given-names>Rasla</given-names></string-name>, <string-name><surname>Patrick</surname> <given-names>Reichert</given-names></string-name>, <string-name><surname>Viviana</surname> <given-names>Romero</given-names></string-name>, <string-name><surname>Elien</surname> <given-names>Ruyssinck</given-names></string-name>, <string-name><given-names>Julie M.</given-names> <surname>Sahalie</surname></string-name>, <string-name><surname>Annemarie</surname> <given-names>Scholz</given-names></string-name>, <string-name><given-names>Akash A.</given-names> <surname>Shah</surname></string-name>, <string-name><surname>Amitabh</surname> <given-names>Sharma</given-names></string-name>, <string-name><surname>Yun</surname> <given-names>Shen</given-names></string-name>, <string-name><surname>Kerstin</surname> <given-names>Spirohn</given-names></string-name>, <string-name><surname>Stanley</surname> <given-names>Tam</given-names></string-name>, <string-name><given-names>Alexander O.</given-names> <surname>Tejeda</surname></string-name>, <string-name><given-names>Shelly A.</given-names> <surname>Trigg</surname></string-name>, <string-name><surname>Jean-Claude</surname> <given-names>Twizere</given-names></string-name>, <string-name><surname>Kerwin</surname> <given-names>Vega</given-names></string-name>, <string-name><surname>Jennifer</surname> <given-names>Walsh</given-names></string-name>, <string-name><given-names>Michael E.</given-names> <surname>Cusick</surname></string-name>, <string-name><surname>Yu</surname> <given-names>Xia</given-names></string-name>, <string-name><surname>Albert-L&#x00E1;szl&#x00F3;</surname> <given-names>Barab&#x00E1;si</given-names></string-name>, <string-name><given-names>Lilia M.</given-names> <surname>Iakoucheva</surname></string-name>, <string-name><surname>Patrick</surname> <given-names>Aloy</given-names></string-name>, <string-name><surname>Javier De</surname> <given-names>Las Rivas</given-names></string-name>, <string-name><surname>Jan</surname> <given-names>Tavernier</given-names></string-name>, <string-name><given-names>Michael A.</given-names> <surname>Calderwood</surname></string-name>, <string-name><given-names>David E.</given-names> <surname>Hill</surname></string-name>, <string-name><surname>Tong</surname> <given-names>Hao</given-names></string-name>, <string-name><given-names>Frederick P.</given-names> <surname>Roth</surname></string-name>, <string-name><surname>Marc</surname> <given-names>Vidal</given-names></string-name> (<year>2014</year>) <source>Cell</source>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2014.10.050</pub-id></mixed-citation></ref>
<ref id="c139"><label>139.</label><mixed-citation publication-type="journal"><article-title>Uncovering disease-disease relationships through the incomplete</article-title> <string-name><given-names>interactome J.</given-names> <surname>Menche</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Sharma</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Kitsak</surname></string-name>, <string-name><given-names>S. D.</given-names> <surname>Ghiassian</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Vidal</surname></string-name>, <string-name><given-names>J.</given-names> <surname>Loscalzo</surname></string-name>, <string-name><given-names>A.-L.</given-names> <surname>Barabasi</surname></string-name> (<year>2015</year>) <source>Science</source>. doi:<pub-id pub-id-type="doi">10.1126/science.1257601</pub-id></mixed-citation></ref>
<ref id="c140"><label>140.</label><mixed-citation publication-type="journal"><article-title>The GOA database: Gene Ontology annotation updates for 2015</article-title> <string-name><given-names>R. P.</given-names> <surname>Huntley</surname></string-name>, <string-name><given-names>T.</given-names> <surname>Sawford</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Mutowo-Meullenet</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Shypitsyna</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Bonilla</surname></string-name>, <string-name><given-names>M. J.</given-names> <surname>Martin</surname></string-name>, <string-name><given-names>C.</given-names> <surname>O'Donovan</surname></string-name> (<year>2014</year>) <source>Nucleic Acids Research</source>. doi:<pub-id pub-id-type="doi">10.1093/nar/gku1113</pub-id></mixed-citation></ref>
<ref id="c141"><label>141.</label><mixed-citation publication-type="journal"><article-title>Compiling Gene Ontology annotations into an easy-to-use format</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Casey</surname> <given-names>Greene</given-names></string-name>, <string-name><given-names>Venkat</given-names> <surname>Malladi</surname></string-name>, <string-name><surname>Frederic</surname> <given-names>Bastian</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d39</pub-id></mixed-citation></ref>
<ref id="c142"><label>142.</label><mixed-citation publication-type="journal"><article-title>gene-ontology: Initial zenodo release</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Casey</surname> <given-names>Greene</given-names></string-name>, <string-name><surname>Venkat</surname> <given-names>Malladi</given-names></string-name>, <string-name><surname>Frederic</surname> <given-names>Bastian</given-names></string-name>, <string-name><surname>Sergio</surname> <given-names>Baranzini</given-names></string-name> (<year>2015</year>) <source>Zenodo</source>. doi:<pub-id pub-id-type="doi">10.5281/zenodo.21711</pub-id></mixed-citation></ref>
<ref id="c143"><label>143.</label><mixed-citation publication-type="journal"><article-title>Gene Expression Omnibus: NCBI gene expression and hybridization array data repository</article-title> <string-name><given-names>R.</given-names> <surname>Edgar</surname></string-name> (<year>2002</year>) <source>Nucleic Acids Research</source>. doi:<pub-id pub-id-type="doi">10.1093/nar/30.1.207</pub-id></mixed-citation></ref>
<ref id="c144"><label>144.</label><mixed-citation publication-type="journal"><article-title>NCBI GEO: archive for functional genomics data sets--update</article-title> <string-name><given-names>T.</given-names> <surname>Barrett</surname></string-name>, <string-name><given-names>S. E.</given-names> <surname>Wilhite</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Ledoux</surname></string-name>, <string-name><given-names>C.</given-names> <surname>Evangelista</surname></string-name>, <string-name><given-names>I. F.</given-names> <surname>Kim</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Tomashevsky</surname></string-name>, <string-name><given-names>K. A.</given-names> <surname>Marshall</surname></string-name>, <string-name><given-names>K. H.</given-names> <surname>Phillippy</surname></string-name>, <string-name><given-names>P. M.</given-names> <surname>Sherman</surname></string-name>, <string-name><given-names>M.</given-names> <surname>Holko</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Yefanov</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Lee</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Zhang</surname></string-name>, <string-name><given-names>C. L.</given-names> <surname>Robertson</surname></string-name>, <string-name><given-names>N.</given-names> <surname>Serova</surname></string-name>, <string-name><given-names>S.</given-names> <surname>Davis</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Soboleva</surname></string-name> (<year>2012</year>) <source>Nucleic Acids Research</source>. doi:<pub-id pub-id-type="doi">10.1093/nar/gks1193</pub-id></mixed-citation></ref>
<ref id="c145"><label>145.</label><mixed-citation publication-type="journal"><article-title>dhimmel/lincs v2.0: Refined consensus signatures from LINCS L1000</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Leo</surname> <given-names>Brueggeman</given-names></string-name>, <string-name><surname>Sergio</surname> <given-names>Baranzini</given-names></string-name> (<year>2016</year>) <source>Zenodo</source>. doi:<pub-id pub-id-type="doi">10.5281/zenodo.47223</pub-id></mixed-citation></ref>
<ref id="c146"><label>146.</label><mixed-citation publication-type="journal"><article-title>l1000.db: SQLite database of LINCS L1000 metadata</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Leo</surname> <given-names>Brueggeman</given-names></string-name>, <string-name><surname>Sergio</surname> <given-names>Baranzini</given-names></string-name> (<year>2016</year>) <source>Figshare</source>. doi:<pub-id pub-id-type="doi">10.6084/m9.figshare.3085837.v1</pub-id></mixed-citation></ref>
<ref id="c147"><label>147.</label><mixed-citation publication-type="journal"><article-title>Computing consensus transcriptional profiles for LINCS L1000 perturbations</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Caty</surname> <given-names>Chung</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d43</pub-id></mixed-citation></ref>
<ref id="c148"><label>148.</label><mixed-citation publication-type="journal"><article-title>Consensus signatures for LINCS L1000 perturbations</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Leo</surname> <given-names>Brueggeman</given-names></string-name>, <string-name><surname>Sergio</surname> <given-names>Baranzini</given-names></string-name> (<year>2016</year>) <source>Figshare</source>. doi:<pub-id pub-id-type="doi">10.6084/m9.figshare.3085426.v1</pub-id></mixed-citation></ref>
<ref id="c149"><label>149.</label><mixed-citation publication-type="journal"><article-title>Assessing the imputation quality of gene expression in LINCS L1000</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name> (<year>2016</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d185</pub-id></mixed-citation></ref>
<ref id="c150"><label>150.</label><mixed-citation publication-type="journal"><article-title>Positive correlations between knockdown and overexpression profiles from LINCS L1000</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Casey</surname> <given-names>Greene</given-names></string-name>, <string-name><surname>Lars</surname> <given-names>Juhl Jensen</given-names></string-name> (<year>2016</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d171</pub-id></mixed-citation></ref>
<ref id="c151"><label>151.</label><mixed-citation publication-type="journal"><article-title>Announcing PharmacotherapyDB: the Open Catalog of Drug Therapies for Disease</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name> (<year>2016</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d182</pub-id></mixed-citation></ref>
<ref id="c152"><label>152.</label><mixed-citation publication-type="journal"><article-title>PharmacotherapyDB 1.0: the open catalog of drug therapies for disease</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Pouya</surname> <given-names>Khankhanian</given-names></string-name>, <string-name><given-names>Christine S.</given-names> <surname>Hessler</surname></string-name>, <string-name><given-names>Ari J.</given-names> <surname>Green</surname></string-name>, <string-name><surname>Sergio</surname> <given-names>Baranzini</given-names></string-name> (<year>2016</year>) <source>Figshare</source>. doi:<pub-id pub-id-type="doi">10.6084/m9.figshare.3103054</pub-id></mixed-citation></ref>
<ref id="c153"><label>153.</label><mixed-citation publication-type="journal"><article-title>dhimmel/indications v1.0. PharmacotherapyDB: the open catalog of drug therapies for disease</article-title> <string-name><given-names>Daniel S.</given-names> <surname>Himmelstein</surname></string-name>, <string-name><surname>Pouya</surname> <given-names>Khankhanian</given-names></string-name>, <string-name><given-names>Christine S.</given-names> <surname>Hessler</surname></string-name>, <string-name><given-names>Ari J.</given-names> <surname>Green</surname></string-name>, <string-name><given-names>Sergio E.</given-names> <surname>Baranzini</surname></string-name> (<year>2016</year>) <source>Zenodo</source>. doi:<pub-id pub-id-type="doi">10.5281/zenodo.47664</pub-id></mixed-citation></ref>
<ref id="c154"><label>154.</label><mixed-citation publication-type="journal"><article-title>How should we construct a catalog of drug indications?</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Benjamin</surname> <given-names>Good</given-names></string-name>, <string-name><surname>Tudor</surname> <given-names>Oprea</given-names></string-name>, <string-name><surname>Allison</surname> <given-names>McCoy</given-names></string-name>, <string-name><surname>Antoine</surname> <given-names>Lizee</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d21</pub-id></mixed-citation></ref>
<ref id="c155"><label>155.</label><mixed-citation publication-type="journal"><article-title>Development and evaluation of an ensemble resource linking medications to their indications</article-title> <string-name><given-names>W.-Q.</given-names> <surname>Wei</surname></string-name>, <string-name><given-names>R. M.</given-names> <surname>Cronin</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Xu</surname></string-name>, <string-name><given-names>T. A.</given-names> <surname>Lasko</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Bastarache</surname></string-name>, <string-name><given-names>J. C.</given-names> <surname>Denny</surname></string-name> (<year>2013</year>) <source>Journal of the American Medical Informatics Association</source>. doi:<pub-id pub-id-type="doi">10.1136/amiajnl-2012-001431</pub-id></mixed-citation></ref>
<ref id="c156"><label>156.</label><mixed-citation publication-type="journal"><article-title>LabeledIn: Cataloging labeled indications for human drugs</article-title> <string-name><surname>Ritu</surname> <given-names>Khare</given-names></string-name>, <string-name><surname>Jiao</surname> <given-names>Li</given-names></string-name>, <string-name><surname>Zhiyong</surname> <given-names>Lu</given-names></string-name> (<year>2014</year>) <source>Journal of Biomedical Informatics</source>. doi:<pub-id pub-id-type="doi">10.1016/j.jbi.2014.08.004</pub-id></mixed-citation></ref>
<ref id="c157"><label>157.</label><mixed-citation publication-type="journal"><article-title>Scaling drug indication curation through crowdsourcing</article-title> <string-name><given-names>R.</given-names> <surname>Khare</surname></string-name>, <string-name><given-names>J. D.</given-names> <surname>Burger</surname></string-name>, <string-name><given-names>J. S.</given-names> <surname>Aberdeen</surname></string-name>, <string-name><given-names>D. W.</given-names> <surname>Tresner-Kirsch</surname></string-name>, <string-name><given-names>T. J.</given-names> <surname>Corrales</surname></string-name>, <string-name><given-names>L.</given-names> <surname>Hirchman</surname></string-name>, <string-name><given-names>Z.</given-names> <surname>Lu</surname></string-name> (<year>2015</year>) <source>Database</source>. doi:<pub-id pub-id-type="doi">10.1093/database/bav016</pub-id></mixed-citation></ref>
<ref id="c158"><label>158.</label><mixed-citation publication-type="journal"><article-title>Processing LabeledIn to extract indications</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Ritu</surname> <given-names>Khare</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d46</pub-id></mixed-citation></ref>
<ref id="c159"><label>159.</label><mixed-citation publication-type="journal"><article-title>Development and evaluation of a crowdsourcing methodology for knowledge base construction: identifying relationships between clinical problems and medications</article-title> <string-name><given-names>A. B.</given-names> <surname>McCoy</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Wright</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Laxmisan</surname></string-name>, <string-name><given-names>M. J.</given-names> <surname>Ottosen</surname></string-name>, <string-name><given-names>J. A.</given-names> <surname>McCoy</surname></string-name>, <string-name><given-names>D.</given-names> <surname>Butten</surname></string-name>, <string-name><given-names>D. F.</given-names> <surname>Sittig</surname></string-name> (<year>2012</year>) <source>Journal of the American Medical Informatics Association</source>. doi:<pub-id pub-id-type="doi">10.1136/amiajnl-2012-000852</pub-id></mixed-citation></ref>
<ref id="c160"><label>160.</label><mixed-citation publication-type="journal"><article-title>Extracting indications from the ehrlink resource</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d62</pub-id></mixed-citation></ref>
<ref id="c161"><label>161.</label><mixed-citation publication-type="journal"><article-title>Expert curation of our indication catalog for disease-modifying treatments</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Pouya</surname> <given-names>Khankhanian</given-names></string-name>, <string-name><surname>Chrissy</surname> <given-names>Hessler</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d95</pub-id></mixed-citation></ref>
<ref id="c162"><label>162.</label><mixed-citation publication-type="journal"><article-title>Enabling reproducibility and reuse</article-title> <string-name><surname>Jesse</surname> <given-names>Spaulding</given-names></string-name>, <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Casey</surname> <given-names>Greene</given-names></string-name>, <string-name><surname>Benjamin</surname> <given-names>Good</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d23</pub-id></mixed-citation></ref>
<ref id="c163"><label>163.</label><mixed-citation publication-type="journal"><article-title>The need and drive for open data in biomedical publishing</article-title> <string-name><given-names>Iain</given-names> <surname>Hrynaszkiewicz</surname></string-name> (<year>2011</year>) <source>Serials: The Journal for the Serials Community</source>. doi:<pub-id pub-id-type="doi">10.1629/2431</pub-id></mixed-citation></ref>
<ref id="c164"><label>164.</label><mixed-citation publication-type="journal"><article-title>The Open Knowledge Foundation: Open Data Means Better Science</article-title> <string-name><given-names>Jennifer C.</given-names> <surname>Molloy</surname></string-name> (<year>2011</year>) <source>PLoS Biology</source>. doi:<pub-id pub-id-type="doi">10.1371/journal.pbio.1001195</pub-id></mixed-citation></ref>
<ref id="c165"><label>165.</label><mixed-citation publication-type="journal"><article-title>Data reuse and the open data citation advantage</article-title> <string-name><given-names>Heather A.</given-names> <surname>Piwowar</surname></string-name>, <string-name><given-names>Todd J.</given-names> <surname>Vision</surname></string-name> (<year>2013</year>) <source>PeerJ</source>. doi:<pub-id pub-id-type="doi">10.7717/peerj.175</pub-id></mixed-citation></ref>
<ref id="c166"><label>166.</label><mixed-citation publication-type="journal"><article-title>Best Practices for Computational Science: Software Infrastructure and Environments for Reproducible and Extensible Research</article-title> (<year>2014</year>) <source>Journal of Open Research Software</source>. doi:<pub-id pub-id-type="doi">10.5334/jors.ay</pub-id></mixed-citation></ref>
<ref id="c167"><label>167.</label><mixed-citation publication-type="journal"><article-title>Disclose all data in publications</article-title> <string-name><surname>Keith</surname> <given-names>Baggerly</given-names></string-name> (<year>2010</year>) <source>Nature</source>. doi:<pub-id pub-id-type="doi">10.1038/467401b</pub-id></mixed-citation></ref>
<ref id="c168"><label>168.</label><mixed-citation publication-type="journal"><article-title>Are We Wasting a Good Crisis? The Availability of Psychological Research Data after the Storm</article-title> <string-name><surname>Wolf</surname> <given-names>Vanpaemel</given-names></string-name>, <string-name><surname>Maarten</surname> <given-names>Vermorgen</given-names></string-name>, <string-name><surname>Leen</surname> <given-names>Deriemaecker</given-names></string-name>, <string-name><surname>Gert</surname> <given-names>Storms</given-names></string-name> (<year>2015</year>) <source>Collabra</source>. doi:<pub-id pub-id-type="doi">10.1525/collabra.13</pub-id></mixed-citation></ref>
<ref id="c169"><label>169.</label><mixed-citation publication-type="journal"><article-title>Open by default: a proposed copyright license and waiver agreement for open access research and data in peer-reviewed journals</article-title> <string-name><surname>Iain</surname> <given-names>Hrynaszkiewicz</given-names></string-name>, <string-name><given-names>Matthew J</given-names> <surname>Cockerill</surname></string-name> (<year>2012</year>) <source>BMC Research Notes</source>. doi:<pub-id pub-id-type="doi">10.1186/1756-0500-5-494</pub-id></mixed-citation></ref>
<ref id="c170"><label>170.</label><mixed-citation publication-type="journal"><article-title>Creative Commons licenses and the non-commercial condition: Implications for the re-use of biodiversity information</article-title> <string-name><surname>Gregor</surname> <given-names>Hagedorn</given-names></string-name>, <string-name><surname>Daniel</surname> <given-names>Mietchen</given-names></string-name>, <string-name><surname>Robert</surname> <given-names>Morris</given-names></string-name>, <string-name><surname>Donat</surname> <given-names>Agosti</given-names></string-name>, <string-name><surname>Lyubomir</surname> <given-names>Penev</given-names></string-name>, <string-name><surname>Walter</surname> <given-names>Berendsohn</given-names></string-name>, <string-name><surname>Donald</surname> <given-names>Hobern</given-names></string-name> (<year>2011</year>) <source>ZooKeys</source>. doi:<pub-id pub-id-type="doi">10.3897/zookeys.150.2189</pub-id></mixed-citation></ref>
<ref id="c171"><label>171.</label><mixed-citation publication-type="journal"><article-title>One network to rule them all</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Lars</surname> <given-names>Juhl Jensen</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d102</pub-id></mixed-citation></ref>
<ref id="c172"><label>172.</label><mixed-citation publication-type="journal"><article-title>Legal confusion threatens to slow data science</article-title> <string-name><surname>Simon</surname> <given-names>Oxenham</given-names></string-name> (<year>2016</year>) <source>Nature</source>. doi:<pub-id pub-id-type="doi">10.1038/536016a</pub-id></mixed-citation></ref>
<ref id="c173"><label>173.</label><mixed-citation publication-type="journal"><article-title>Who owns scientific data? The impact of intellectual property rights on the scientific publication chain</article-title> <string-name><surname>Roger</surname> <given-names>Elliott</given-names></string-name> (<year>2005</year>) <source>Learned Publishing</source>. doi:<pub-id pub-id-type="doi">10.1087/0953151053584984</pub-id></mixed-citation></ref>
<ref id="c174"><label>174.</label><mixed-citation publication-type="journal"><article-title>Integrating resources with disparate licensing into an open network</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Lars</surname> <given-names>Juhl Jensen</given-names></string-name>, <string-name><surname>MacKenzie</surname> <given-names>Smith</given-names></string-name>, <string-name><surname>Katie</surname> <given-names>Fortney</given-names></string-name>, <string-name><surname>Caty</surname> <given-names>Chung</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d107</pub-id></mixed-citation></ref>
<ref id="c175"><label>175.</label><mixed-citation publication-type="journal"><article-title>MSigDB licensing</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d108</pub-id></mixed-citation></ref>
<ref id="c176"><label>176.</label><mixed-citation publication-type="journal"><article-title>Incomplete Interactome licensing</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d111</pub-id></mixed-citation></ref>
<ref id="c177"><label>177.</label><mixed-citation publication-type="journal"><article-title>LINCS L1000 licensing</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d110</pub-id></mixed-citation></ref>
<ref id="c178"><label>178.</label><mixed-citation publication-type="journal"><article-title>Molecular signatures database (MSigDB) 3.0</article-title> <string-name><given-names>A.</given-names> <surname>Liberzon</surname></string-name>, <string-name><given-names>A.</given-names> <surname>Subramanian</surname></string-name>, <string-name><given-names>R.</given-names> <surname>Pinchback</surname></string-name>, <string-name><given-names>H.</given-names> <surname>Thorvaldsdottir</surname></string-name>, <string-name><given-names>P.</given-names> <surname>Tamayo</surname></string-name>, <string-name><given-names>J. P.</given-names> <surname>Mesirov</surname></string-name> (<year>2011</year>) <source>Bioinformatics</source>. doi:<pub-id pub-id-type="doi">10.1093/bioinformatics/btr260</pub-id></mixed-citation></ref>
<ref id="c179"><label>179.</label><mixed-citation publication-type="journal"><article-title>Assessing the effectiveness of our hetnet permutations Daniel Himmelstein</article-title> (<year>2016</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d178</pub-id></mixed-citation></ref>
<ref id="c180"><label>180.</label><mixed-citation publication-type="journal"><article-title>Randomization Techniques for Graphs</article-title> <string-name><surname>Sami</surname> <given-names>Hanhij&#x00E4;rvi</given-names></string-name>, <string-name><given-names>Gemma C.</given-names> <surname>Garriga</surname></string-name>, <string-name><surname>Kai</surname> <given-names>Puolam&#x00E4;ki</given-names></string-name> (<year>2009</year>) <source>Proceedings of the 2009 SIAM International Conference on Data Mining</source>. doi:<pub-id pub-id-type="doi">10.1137/1.9781611972795.67</pub-id></mixed-citation></ref>
<ref id="c181"><label>181.</label><mixed-citation publication-type="journal"><article-title>Permuting hetnets and implementing randomized edge swaps in cypher</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d136</pub-id></mixed-citation></ref>
<ref id="c182"><label>182.</label><mixed-citation publication-type="journal"><article-title>Are graph databases ready for bioinformatics?</article-title> <string-name><given-names>C. T.</given-names> <surname>Have</surname></string-name>, <string-name><given-names>L. J.</given-names> <surname>Jensen</surname></string-name> (<year>2013</year>) <source>Bioinformatics</source>. doi:<pub-id pub-id-type="doi">10.1093/bioinformatics/btt549</pub-id></mixed-citation></ref>
<ref id="c183"><label>183.</label><mixed-citation publication-type="journal"><article-title>Using the neo4j graph database for hetnets</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d112</pub-id></mixed-citation></ref>
<ref id="c184"><label>184.</label><mixed-citation publication-type="journal"><article-title>dhimmel/hetio v0.2.0: Neo4j export, Cypher query creation, hetnet stats, and other enhancements</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name> (<year>2016</year>) <source>Zenodo</source>. doi:<pub-id pub-id-type="doi">10.5281/zenodo.61571</pub-id></mixed-citation></ref>
<ref id="c185"><label>185.</label><mixed-citation publication-type="journal"><article-title>Hosting Hetionet in the cloud: creating a public Neo4j instance</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name> (<year>2016</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d216</pub-id></mixed-citation></ref>
<ref id="c186"><label>186.</label><mixed-citation publication-type="journal"><article-title>Bioboxes: standardised containers for interchangeable bioinformatics software</article-title> <string-name><surname>Peter</surname> <given-names>Belmann</given-names></string-name>, <string-name><surname>Johannes</surname> <given-names>Dr&#x00F6;ge</given-names></string-name>, <string-name><surname>Andreas</surname> <given-names>Bremges</given-names></string-name>, <string-name><given-names>Alice C.</given-names> <surname>McHardy</surname></string-name>, <string-name><surname>Alexander</surname> <given-names>Sczyrba</given-names></string-name>, <string-name><given-names>Michael D.</given-names> <surname>Barton</surname></string-name> (<year>2015</year>) <source>GigaScience</source>. doi:<pub-id pub-id-type="doi">10.1186/s13742-015-0087-0</pub-id></mixed-citation></ref>
<ref id="c187"><label>187.</label><mixed-citation publication-type="journal"><article-title>Reproducible Computational Workflows with Continuous Analysis</article-title> <string-name><given-names>Brett K</given-names> <surname>Beaulieu-Jones</surname></string-name>, <string-name><given-names>Casey S</given-names> <surname>Greene</surname></string-name> (<year>2016</year>) <source>Cold Spring Harbor Laboratory Press</source>. doi:<pub-id pub-id-type="doi">10.1101/056473</pub-id></mixed-citation></ref>
<ref id="c188"><label>188.</label><mixed-citation publication-type="journal"><article-title>Alternative Transformations to Handle Extreme Values of the Dependent Variable</article-title> <string-name><given-names>John B.</given-names> <surname>Burbidge</surname></string-name>, <string-name><surname>Lonnie</surname> <given-names>Magee</given-names></string-name>, <string-name><given-names>A.</given-names> <surname>Leslie Robb</surname></string-name> (<year>1988</year>) <source>Journal of the American Statistical Association</source>. doi:<pub-id pub-id-type="doi">10.2307/2288929</pub-id></mixed-citation></ref>
<ref id="c189"><label>189.</label><mixed-citation publication-type="journal"><article-title>Transforming DWPCs for hetnet edge prediction</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Pouya</surname> <given-names>Khankhanian</given-names></string-name>, <string-name><surname>Antoine</surname> <given-names>Lizee</given-names></string-name> (<year>2016</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d193</pub-id></mixed-citation></ref>
<ref id="c190"><label>190.</label><mixed-citation publication-type="journal"><article-title>Our hetnet edge prediction methodology: the modeling framework for Project Rephetio</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name> (<year>2016</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d210</pub-id></mixed-citation></ref>
<ref id="c191"><label>191.</label><mixed-citation publication-type="journal"><article-title>Assessing the informativeness of features</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d115</pub-id></mixed-citation></ref>
<ref id="c192"><label>192.</label><mixed-citation publication-type="journal"><article-title>Edge dropout contamination in hetnet edge prediction</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name> (<year>2016</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d215</pub-id></mixed-citation></ref>
<ref id="c193"><label>193.</label><mixed-citation publication-type="journal"><article-title>Network Edge Prediction: Estimating the prior</article-title> <string-name><surname>Antoine</surname> <given-names>Lizee</given-names></string-name>, <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name> (<year>2016</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d201</pub-id></mixed-citation></ref>
<ref id="c194"><label>194.</label><mixed-citation publication-type="journal"><article-title>Network Edge Prediction: how to deal with self-testing</article-title> <string-name><surname>Antoine</surname> <given-names>Lizee</given-names></string-name>, <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name> (<year>2016</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d194</pub-id></mixed-citation></ref>
<ref id="c195"><label>195.</label><mixed-citation publication-type="journal"><article-title>Cataloging drug&#x2013;disease therapies in the ClinicalTrials.gov database</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name> (<year>2016</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d212</pub-id></mixed-citation></ref>
<ref id="c196"><label>196.</label><mixed-citation publication-type="journal"><article-title>Rephetio: Repurposing drugs on a hetnet [proposal]</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Antoine</surname> <given-names>Lizee</given-names></string-name>, <string-name><surname>Pouya</surname> <given-names>Khankhanian</given-names></string-name>, <string-name><surname>Leo</surname> <given-names>Brueggeman</given-names></string-name>, <string-name><surname>Sabrina</surname> <given-names>Chen</given-names></string-name>, <string-name><surname>Dexter</surname> <given-names>Hadley</given-names></string-name>, <string-name><surname>Chrissy</surname> <given-names>Hessler</given-names></string-name>, <string-name><surname>Ari</surname> <given-names>Green</given-names></string-name>, <string-name><surname>Sergio</surname> <given-names>Baranzini</given-names></string-name> (<year>2015</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.a5</pub-id></mixed-citation></ref>
<ref id="c197"><label>197.</label><mixed-citation publication-type="journal"><article-title>Measuring user contribution and content creation</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Antoine</surname> <given-names>Lizee</given-names></string-name> (<year>2016</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d200</pub-id></mixed-citation></ref>
<ref id="c198"><label>198.</label><mixed-citation publication-type="journal"><article-title>This revolution will be digitized: online tools for radical collaboration</article-title> <string-name><given-names>C.</given-names> <surname>Patil</surname></string-name>, <string-name><given-names>V.</given-names> <surname>Siegel</surname></string-name> (<year>2009</year>) <source>Disease Models &#x0026; Mechanisms</source>. doi:<pub-id pub-id-type="doi">10.1242/dmm.003285</pub-id></mixed-citation></ref>
<ref id="c199"><label>199.</label><mixed-citation publication-type="journal"><article-title>Publishing the research process</article-title> <string-name><surname>Daniel</surname> <given-names>Mietchen</given-names></string-name>, <string-name><surname>Ross</surname> <given-names>Mounce</given-names></string-name>, <string-name><surname>Lyubomir</surname> <given-names>Penev</given-names></string-name> (<year>2015</year>) <source>Research Ideas and Outcomes</source>. doi:<pub-id pub-id-type="doi">10.3897/rio.1.e7547</pub-id></mixed-citation></ref>
<ref id="c200"><label>200.</label><mixed-citation publication-type="journal"><article-title>The waiting game</article-title> <string-name><surname>Kendall</surname> <given-names>Powell</given-names></string-name> (<year>2016</year>) <source>Nature</source>. doi:<pub-id pub-id-type="doi">10.1038/530148a</pub-id></mixed-citation></ref>
<ref id="c201"><label>201.</label><mixed-citation publication-type="journal"><article-title>Accelerating scientific publication in biology</article-title> <string-name><given-names>Ronald D.</given-names> <surname>Vale</surname></string-name> (<year>2015</year>) <source>Proceedings of the National Academy of Sciences</source>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1511912112</pub-id></mixed-citation></ref>
<ref id="c202"><label>202.</label><mixed-citation publication-type="journal"><article-title>Reproducibility: A tragedy of errors</article-title> <string-name><given-names>David B.</given-names> <surname>Allison</surname></string-name>, <string-name><given-names>Andrew W.</given-names> <surname>Brown</surname></string-name>, <string-name><given-names>Brandon J.</given-names> <surname>George</surname></string-name>, <string-name><given-names>Kathryn A.</given-names> <surname>Kaiser</surname></string-name> (<year>2016</year>) <source>Nature</source>. doi:<pub-id pub-id-type="doi">10.1038/530027a</pub-id></mixed-citation></ref>
<ref id="c203"><label>203.</label><mixed-citation publication-type="journal"><article-title>Workshop to analyze LINCS data for the Systems Pharmacology course at UCSF</article-title> <string-name><surname>Daniel</surname> <given-names>Himmelstein</given-names></string-name>, <string-name><surname>Kathleen</surname> <given-names>Keough</given-names></string-name>, <string-name><surname>Misha</surname> <given-names>Vysotskiy</given-names></string-name>, <string-name><surname>Jeffrey</surname> <given-names>Kim</given-names></string-name>, <string-name><surname>Beau</surname> <given-names>Norgeot</given-names></string-name>, <string-name><surname>Julia</surname> <given-names>Cluceru</given-names></string-name>, <string-name><surname>Marjorie</surname> <given-names>Imperial</given-names></string-name>, <string-name><surname>Emmalyn</surname> <given-names>Chen</given-names></string-name>, <string-name><surname>Jasleen</surname> <given-names>Sodhi</given-names></string-name>, <string-name><surname>Elizabeth</surname> <given-names>Levy</given-names></string-name> (<year>2016</year>) <source>Thinklab</source>. doi:<pub-id pub-id-type="doi">10.15363/thinklab.d181</pub-id></mixed-citation></ref>
<ref id="c204"><label>204.</label><mixed-citation publication-type="journal"><article-title>Why we are teaching science wrong, and how to make it right</article-title> <string-name><given-names>M. Mitchell</given-names> <surname>Waldrop</surname></string-name> (<year>2015</year>) <source>Nature</source>. doi:<pub-id pub-id-type="doi">10.1038/523272a</pub-id></mixed-citation></ref>
<ref id="c205"><label>205.</label><mixed-citation publication-type="journal"><article-title>Going paperless: The digital lab</article-title> <string-name><surname>Jim</surname> <given-names>Giles</given-names></string-name> (<year>2012</year>) <source>Nature</source>. doi:<pub-id pub-id-type="doi">10.1038/481430a</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>